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ABSTRACT OF DISSERTATION  
 
 
 
 
CONTRIBUTION OF NUCLEUS ACCUMBENS CORE TO IMPULSIVE CHOICE: 
ROLE OF DOPAMINE AND GLUTAMATE SYSTEMS 
 
Impulsive choice refers to the inability to delay gratification and is associated with 
increased drug abuse vulnerability.  Understanding the underlying neural 
mechanisms linking impulsive choice and drug abuse can contribute to improved 
treatment options for individuals with substance use disorders.  Evidence 
suggests a major role for nucleus accumbens core (NAcc) in impulsive choice 
and the reinforcing effects of drugs of abuse.  The neurotransmitters glutamate 
(Glu) and dopamine (DA) are implicated in the neural adaptations observed in 
drug addiction; however, the role of intra-NAcc Glu and DA in impulsive choice is 
unclear.  Rats were trained in a delay discounting task, in which animals chose 
between a small, immediate reinforcer and large, delayed reinforcer.  
Consistently choosing the small, immediate reinforcer was considered to reflect 
increased impulsivity.  Following delay discounting, in vitro receptor 
autoradiography was performed to quantify the number of N-methyl-D-aspartate 
(NMDA) receptors and dopamine transporters (DAT) in NAcc and nucleus 
accumbens shell (NAcSh).  In a separate experiment, rats were trained in delay 
discounting and were implanted with guide cannulae into NAcc.  Following 
surgery, rats received microinfusions of either a) the Glu-selective ligands MK-
801 (noncompetitive NMDA receptor channel blocker; 0, 0.3, and 1.0 µg), AP-5 
(competitive NMDA receptor antagonist; 0, 0.3, and 1.0 µg), ifenprodil (NMDA 
NR2B subunit antagonist; 0, 0.3, and 1.0 µg), and CNQX (AMPA receptor 
antagonist; 0, 0.2, and 0.5 µg) or b) the DA-selective ligands SKF 38393 (D1-like 
receptor agonist; 0, 0.03, and 0.1 µg), SCH 23390 (D1-like receptor antagonist; 
0, 0.3, and 1.0 µg), quinpirole (D2-like receptor agonist; 0, 0.3, and 1.0 µg), and 
eticlopride (D2-like receptor antagonist; 0, 0.3, and 1.0 µg).  In NAcc and NAcSh, 
NMDA receptor and DAT expression did not differ between high and low 
	   	   	  
impulsive rats.  Furthermore, intra-NAcc administration of NDMA and DA 
receptor ligands did not significantly alter impulsive choice.  These results 
suggest that Glu and DA systems within NAcc do not directly mediate impulsive 
decision making.  Future work is needed to determine the precise role of NAcc in 
mediating impulsive choice.        
KEYWORDS: Impulsive Choice, Nucleus Accumbens Core, Glutamate, 
Dopamine, Rat 
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Chapter 1: Introduction 
Impulsivity 
 Impulsivity is a multifaceted construct that includes lack of inhibitory 
control, lack of forethought, and inability to delay gratification (see Evenden, 
1999; Whiteside & Lynam, 2001 for reviews).  The construct of impulsivity can be 
measured using personality questionnaires and behavioral studies.  Numerous 
personality questionnaires have been developed to measure impulsivity.  Some 
of the most widely used questionnaires include the Barratt Impulsiveness Scale-
11 (BIS-11; Patton, Stanford, & Barratt, 1995), which encompasses the 
subscales attentional impulsiveness, motor impulsiveness, and non-planning 
impulsiveness; the I-7 Impulsiveness Questionnaire (Eysenck, Pearson, Easting, 
& Allsopp, 1985), which is composed of the subscales impulsiveness, 
venturesomeness, and empathy; and the UPPS Impulsive Behavior Scale 
(Whiteside & Lynam, 2001), which includes urgency, (lack of) premeditation, 
(lack of) perseverance, and sensation seeking.  
Dickman (1990) emphasizes two broad types of impulsivity: functional and 
dysfunctional.  Functional impulsivity is defined as the tendency to act with little 
forethought when the situation is optimal.  In contrast, dysfunctional impulsivity is 
defined as the tendency to act with less forethought, which can lead to 
problematic decisions.  Distinguishing between functional and dysfunctional 
impulsivity is important because this distinction illustrates that impulsivity is not 
always disadvantageous.   
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One criticism of personality measures is that they can suffer from the 
“jingle and jangle” fallacies (Block, 1995; see Whiteside and Lynam, 2001 for a 
discussion).  According to Whiteside and Lynam (2001), the jingle fallacy refers 
to situations in which two different impulsivity constructs are given the same 
label, and the jangle fallacy refers to situations in which different labels are used 
to describe the same construct.  These fallacies are problematic because they 
can impede our understanding of the underlying processes involved in 
impulsivity.  One way to avoid the jingle and jangle fallacies is to use behavioral 
studies to test the various types of impulsivity.  
Impulsive Action and Impulsive Choice 
Most of the behavioral procedures measuring impulsivity can be fractioned 
into two broad categories: impulsive action and impulsive choice (see 
Winstanley, Olausson, Taylor, & Jentsch, 2010 for a full review).  Impulsive 
action is conceptualized as motor impulsivity; humans and animals that fail to 
inhibit prepotent responses are considered to have higher levels of motor 
impulsivity.  The primary behavioral tasks used to measure impulsive action are 
the stop signal reaction time (SSRT), the go/no-go, and the five-choice serial 
reaction time (5CSRT) tasks (see Winstanley et al., 2010).  In the SSRT, 
subjects are required to inhibit responses they have already initiated when 
presented with a cue (Logan, Cowan, & Davis, 1984).  In go/no-go tasks, 
subjects are required to either initiate a response (go) or inhibit a response (no-
go) when presented with different cues (Newman, Widom, & Nathan, 1985).  In 
the 5CSRT task, animals are trained to respond to a stimulus that is presented in 
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one of five apertures.  The animal is required to wait for a period of time before 
initiating a response (Carli, Robbins, Evenden, & Everitt, 1983).   
The SSRT and go/no-go tasks can be used with human (Logan et al., 
1984; Newman et al., 1985) and animal subjects (Eagle & Robbins, 2003; Feola, 
de Wit, & Richards, 2000; Iverson & Mishkin, 1970; Liu, Heitz, & Bradberry, 2009; 
Terman & Terman, 1973), but the 5CSRT is currently only measured in animals. 
However, the 5CSRT is considered to be an animal analog of the continuous 
performance task, in which humans are required to scan a 5-digit sequence and 
respond when the number matches a target stimulus (Rosvold, Mirsky, Sarason, 
Bransome, & Beck, 1956; see Winstanley et al., 2010 for a discussion).  
Impulsive choice is conceptualized as the inability to delay gratification 
and is often measured with delay discounting tasks.  The term discounting refers 
to the decrease in subjective value of a reinforcer as a function of the delay to its 
delivery.  In a typical delay discounting procedure, humans and animals choose 
between a small magnitude reinforcer delivered immediately and a large 
magnitude reinforcer delivered after a delay.  Consistently choosing the smaller, 
immediate reward over the larger, delayed reward is often considered to reflect 
impulsive behavior (Ainslie, 1975).  Discounting of delayed rewards is observed 
in various species, including humans (e.g., Rachlin, Raineri, & Cross, 1991), 
pigeons (e.g., Mazur, 1987), mice (e.g., Mitchell, Reeves, Li, & Phillips, 2006), 
and rats (e.g., Richards, Mitchell, de Wit, & Seiden, 1997).  
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Delay Discounting Paradigms  
Delay discounting is often measured in humans by asking participants to 
choose between two hypothetical monetary rewards differing in magnitude 
(Rachlin et al., 1991).  The value of the larger, delayed monetary reward is held 
constant, whereas the value of the smaller, immediate reward is decreased 
systematically.  The indifference point is the point at which a person switches 
their preference from the small, immediate reinforcer to the large, delayed 
reinforcer.  While there may be some concern about the validity of delay 
discounting when hypothetical rewards are used, results indicate similar rates of 
delay discounting when hypothetical or real rewards are used (Johnson & Bickel, 
2002; Madden, Begotka, Raiff, & Kastern, 2003).  
Multiple procedures can be used to measure delay discounting in animals.   
In the T-maze (Bizot, Le Bihan, Puech, Hamon, & Thiebot, 1999; Rudebeck, 
Walton, Smyth, Bannerman, & Rushworth, 2006), one arm of the maze is 
associated with a small magnitude reinforcer, whereas one arm is paired with a 
larger reinforcer.  If the rat chooses the arm with the larger reinforcer, a gate is 
lowered, and the animal is confined to the arm for a fixed delay before receiving 
reinforcement.  Delays to the larger reinforcer are increased across sessions.  
Because the T-maze paradigm is more labor intense relative to using an 
automated operant procedure, it is infrequently used (Madden & Johnson, 2010). 
Procedures testing delay discounting often rely on the use of operant 
conditioning procedures.  As discussed by Madden and Johnson (2010), there 
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are several common features among studies measuring delay discounting using 
an operant procedure.  Typically, the animal must perform a response that places 
the subject equidistant from the two choice alternatives.  Without this control, an 
animal may respond on a manipulandum because it is closer to that 
manipulandum relative to the alternative manipulandum.  Another common 
feature is the inclusion of forced-choice trials.  During these trials, only one 
alternative is available.  These trials are included to expose the animal to both 
contingencies of reinforcement. 
In the adjusting delay procedure, animals are trained to make choices 
between a large amount of food delivered after an adjusting delay and a smaller 
amount delivered after a fixed delay (Mazur, 1987).  Generally, subjects complete 
blocks of trials, which consist of two forced-choice trials followed by two free-
choice trials.  If the subject chooses the smaller reinforcer on both free-choice 
trials, the delay to the larger reinforcer is decreased (usually by 1 sec).  
Conversely, if an animal chooses the larger reinforcer on both free-choice trials, 
the delay to the larger reinforcer is increased.  The delay to the larger reinforcer 
is not altered if the subject chooses each reinforcer during a block of trials.  Upon 
achieving stability, the mean adjusting delay is calculated and it is termed as the 
“indifference point”.  This procedure is repeated across several fixed delays to 
the smaller reinforcer, and adjusting delays are plotted as a function of the fixed 
delay to the smaller, sooner reinforcer.  
The adjusting delay procedure has received some criticism.  In one study 
Cardinal, Daw, Robbins, and Everitt (2002) trained rats to complete thousands of 
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trials in an adjusting delay task.  Despite the extensive training, rats never 
reached a constrained range of adjusted delays (i.e., adjusted delays never 
stabilized).  Cardinal et al. (2002) concluded that animals are not sensitive to the 
adjusting delay.  It is important to note that Cardinal et al. (2002) adjusted the 
delay to the large magnitude reinforcer by 20%-30% (range: 0.4 – 9.0 seconds), 
whereas Mazur (1987) adjusted the delay in 1-second increments.  The large 
adjustments to the delay to the large reward in the Cardinal et al. (2002) study 
may have resulted in instable indifference points (see Madden & Johnson, 2010).      
The adjusting amount procedure developed by Richards et al. (1997) is 
similar to the adjusting delay procedure.  However, delays stay constant within a 
session, whereas the size of the delayed reinforcer varies depending on the 
animal’s response on the previous trial.  Evidence suggest that the rate of 
discounting in an adjusting amount procedure is similar to the discounting 
observed in an adjusting delay procedure, suggesting that these tasks share 
similar underlying processes (Green, Myerson, Shah, Estle, & Holt, 2007).   
 Evenden and Ryan (1996) developed a discounting procedure that is 
commonly used to measure impulsive choice in both humans and animals.  This 
task incorporates blocks of trials, in which the delay for obtaining the larger 
reward increases within a single session (Evenden & Ryan, 1996), although the 
delay for obtaining the large reinforcer can be manipulated between sessions 
(Mobini, Chiang, Ho, Bradshaw, & Szabadi, 2000).  As the delay of obtaining the 
large reinforcer increases, animals switch their preference to the smaller, 
immediate reinforcer (Evenden & Ryan, 1996).  Importantly, the increased 
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discounting observed across a session is not due to satiation, as animals 
consistently choose a large reinforcer over a small reinforcer when delivery of the 
larger reinforcer is not delayed (Evenden & Ryan, 1996).  One advantage of this 
procedure is that it provides a measure of sensitivity to delayed reinforcement 
during each session.  Also, a measurement of sensitivity to reinforcer amount 
can be measured each session by examining choice for the large reinforcer 
during no-delay trial blocks (i.e., delay = 0 sec).  
Although the original study conducted by Evenden and Ryan (1996) 
increased the delay across blocks of trials, some studies have examined whether 
increasing or decreasing the delay to the larger reinforcer across trial blocks 
alters the rate of discounting of that reinforcer.  Studies with human participants 
have generally shown that increasing the delay within session produces greater 
discounting relative to decreasing the delay within session (Robles & Vargas, 
2008; Robles, Vargas, & Bejarano, 2009; Stillwell & Tunney, 2012; but see 
Robles & Vargas, 2007).  Studies with animals have been mixed; Fox, Hand, and 
Reilly (2008) reported increased discounting using a descending sequence 
relative to an ascending sequence, whereas Slezak and Anderson (2009) 
observed no difference in discounting rate using an ascending or a descending 
sequence.  
Mathematical Models of Discounting  
 Several mathematical models have been proposed to describe the 
relationship between delay and subjective value of a reinforcer.  The exponential 
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discounting model postulates that the subjective value of a good decreases by a 
constant percentage per unit time and can be modeled with the following 
equation:   
V = Ae-kD 
In this equation, V is the subjective value of the delayed reinforcer, A represents 
the amount of the reinforcer, D is the delay to the delivery of the reinforcer, and k 
is a parameter measuring the rate at which delayed reinforcers are discounted 
(Samuelson, 1937).  A higher k value indicates a preference for small, immediate 
reinforcement.  
The exponential model assumes that if a reinforcer is preferred over 
another reinforcer at one point in time, it will be preferred at all other points in 
time.  However, results from studies with humans (Green, Fristoe, & Myerson, 
1994) and animals (Ainslie & Hernstein, 1981; Green & Estle, 2003; Green, 
Fisher, Perlow, & Sherman, 1981) do not support this hypothesis.  For example, 
human participants given a choice between a small hypothetical monetary 
reward (e.g., $20) delivered immediately and a large hypothetical monetary 
reward (e.g., $50) delivered in 1 year often choose the small, immediate reward; 
however, if a delay is added to both rewards (e.g., $20 delivered in 1 year vs. 
$50 delivered in 2 years), participants often switch their preference to the larger 
reward (Green et al., 1994).  The exponential model of discounting does not 
predict these preference reversals (see Green & Myerson, 2004; Madden & 
Johnson, 2010 for reviews).  
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To account for preference reversals, the hyperbolic discounting model 
proposed by Mazur (1987) is often used, which is modeled with the equation:  
V = A/(1 + kD) 
The parameters are identical to those described in the exponential function.  
There is evidence to suggest that the hyperbolic model provides a better fit of 
discounting data relative to the exponential model in humans (Rachlin et al., 
1991; Vuchinich & Simpson, 2000) and animals (Mazur, 1987).  
A hyperboloid function can also be used to model discounting of delayed 
reinforcers (Green, Fry, & Myerson, 1994).  This function is similar to the 
hyperbolic function proposed by Mazur (1987), with the exception that the 
denominator of the hyperbola is raised to a power of s, which is a nonlinear 
scaling of amount and/or time and is generally equal to or less than 1.0 (see 
Green & Myerson, 2004 for a review).  According to Myerson and Green (1995), 
the hyperboloid function provides a better fit of delay discounting behavior 
relative to the hyperbolic, although studies with animals show no reliable 
difference between hyperbolic and hyperboloid functions (Green et al., 2007; 
Mazur, 2000; Richards et al., 1997).  
Given the debate surrounding the different theoretical discounting 
functions, Myerson, Green, and Warusawitharana (2001) propose a “theoretically 
neutral” model of discounting.  Instead of using parameter estimates derived from 
theoretical models of discounting, Myerson et al. (2001) advocate the use of area 
under the curve (AUC) to determine sensitivity to delayed reinforcement.  One 
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advantage of using AUC is that the distribution of AUC values are normally 
distributed, whereas parameter estimates derived from discounting functions 
tend to be positively skewed (Myerson et al., 2001), thus allowing the use of 
parametric statistical analyses to compare discounting rates in different groups of 
subjects.  
Relationship between Impulsive Choice and Drug Abuse  
Clinical cross-sectional studies indicate that drug users are more 
impulsive compared to nonusers (Moeller et al., 2001; Sher & Trull, 1994).  In 
humans, greater delay discounting is observed in opioid-dependent individuals 
(Kirby, Petry, & Bickle, 1999; Madden, Petry, Badger, & Bickel, 1997), cocaine 
users (Coffey, Gudelski, Saladin, & Brady, 2003; Heil, Johnson, Higgins, & 
Bickel, 2006), methamphetamine-dependent individuals (Hoffman et al., 2006), 
alcohol abusers (Field, Christiansen, Cole, & Goudie, 2007; Kollins, 2003; Petry, 
2001a, Vuchinich & Simpson, 1998), and cigarette smokers (Bickel, Odum, & 
Madden, 1999; Mitchell, 1999; Ohmura, Takahashi, & Kitamura, 2005; Reynolds, 
Richards, Horn, & Karraker, 2004).  Furthermore, individuals with a history of 
substance abuse show greater discounting of crack/cocaine, heroin, and 
cigarettes relative to monetary rewards (Bickel et al., 1999; Coffey et al., 2003; 
Madden et al., 1997), reflecting the importance of drug reward over monetary 
rewards in these individuals.   
Although individuals with a history of substance abuse are more impulsive 
relative to matched controls, it is unknown if enhanced impulsivity predisposes an 
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individual to substance abuse or if prolonged drug use increases impulsivity.  
Evidence suggests a bidirectional relationship between impulsivity and drug 
abuse (see de Wit, 2009), and preclinical research has been valuable in this 
regard.  Using a T-maze paradigm to access impulsive choice, Poulos, Le, and 
Parker (1995) found that high impulsive (HiI) rats consume more ethanol relative 
to low impulsive (LoI) rats.  Since the seminal study conducted by Poulos et al. 
(1995), others have examined if impulsive choice predicts vulnerability to 
different stages of drug seeking.  HiI rats acquire cocaine self-administration at a 
faster rate (Perry, Larson, German, Madden, & Carroll, 2005; Perry, Nelson, & 
Perry, 2008), show greater escalation of cocaine self-administration (Anker, 
Perry, Gliddon, & Carroll, 2009), and show greater resistance to extinction (i.e., 
increased responding on a lever in the absence of reinforcement) to cocaine self-
administration (Broos, Diergaarde, Schoffelmeer, Pattij, & De Vries, 2012a) 
relative to LoI rats.  Also, HiI rats self-administer more nicotine and 
methylphenidate relative to LoI rats (Diergaarde et al., 2008; Marusich & Bardo, 
2009), and impulsive choice is predictive of reinstatement to nicotine self-
administration (Diergaarde et al., 2008).  Thus, increased impulsivity is a 
predictor of increased substance abuse vulnerability.   
Some studies have used a behavioral economic approach to measure 
whether impulsivity is associated with inelastic demand for drugs of abuse.  In 
this approach, total consumption of a reinforcer, rather than response rate, is 
measured.  Consumption is measured at a variety of prices (i.e., response 
requirements); if an animal continues to respond for the reinforcer as the price 
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increases, the demand for the reinforcer is considered to be inelastic.  Impulsive 
choice is predictive of inelastic demand for cocaine (Koffarnus & Woods, 2011) 
and nicotine (Diergaarde, van Mourik, Pattij, Schoffelmeer, & De Vries, 2012).  
Interestingly, impulsivity does not predict inelastic demand for alcohol 
(Diergaarde et al., 2012), which contrasts with previous research demonstrating 
that impulsive choice predicts increased alcohol consumption (Poulos et al., 
1995).  These inconsistencies demonstrate the importance of using various drug 
self-administration paradigms to determine the precise relationship between 
sensitivity to delayed reinforcement and drug abuse vulnerability.    
Some caution needs to be taken when interpreting previous studies 
examining delay discounting and operant drug self-administration.  Stephens et 
al. (2010) present one confound to self-administration paradigms.  Self-
administration for psychostimulant drugs may not reflect increased motivation to 
obtain the drug reinforcer; instead, these drugs produce hyperactivity, which may 
increase the likelihood that an animal responds on the drug-paired 
manipulandum.  Rats that show increased cocaine-induced hyperactivity are 
more impulsive in a delay discounting task relative to rats that show an 
attenuated response to cocaine (Stanis, Burns, Sherrill, & Gulley, 2008).  Thus, 
HiI rats may respond more for psychostimulant drugs due to increased drug-
induced hyperactivity.  
Another potential interpretational problem with previous studies assessing 
the role of impulsive choice in drug self-administration is that HiI animals may not 
respond more for drug because of its reinforcing properties; instead, they may be 
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more sensitive to reward-associated stimuli.  For example, HiI rats exhibit more 
sign-tracking conditioned responses compared to LoI rats (Tomie, Aguado, 
Pohrecky, & Benjamin, 1998; but see Lovic, Saunders, Yager, & Robinson, 
2011).  Also, Diergaarde, Pattij, Nawijn, Schoffelmeer, and De Vries (2009) 
showed that high impulsive rats nose poke more for a discrete cue formerly 
paired with sucrose delivery.   
To avoid these potential confounds, Yates, Marusich, Gipson, Beckmann, 
and Bardo (2012) used a non-operant conditioned place preference (CPP) 
paradigm to measure drug reward in HiI and LoI rats.  Impulsive choice was 
predictive of amphetamine CPP; that is, HiI animals spent more time in an 
environment previously paired with amphetamine relative to LoI animals (Yates 
et al., 2012).  These results demonstrate that the increased drug self-
administration of psychostimulants is not simply the result of drug-induced 
hyperactivity or increased sign-tracking.     
Although increased impulsive choice is predictive of different stages of 
psychostimulant addiction, there is little evidence that delay discounting is 
associated with opioid self-administration.  HiI and LoI rats acquire heroin self-
administration at the same rate and self-administer similar amounts of heroin 
(Schippers, Binnekade, Schoffelmeer, Pattij, & De Vries, 2012).  Furthermore, 
impulsive choice is not predictive of extinction to heroin self-administration or 
reinstatement to heroin self-administration (Schippers et al., 2012).  Although the 
relationship between drug addiction and impulsive choice is postulated to be 
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bidirectional (de Wit, 2009), these results suggest that impulsivity is not a 
determinant of opioid abuse.  
Conversely, despite the clear evidence for impulsive choice being a 
predictor of stimulant abuse, research also has demonstrated that drug exposure 
affects impulsive decision making.  Cocaine administration (systemic and self-
administered) increases impulsive choice in rats (Dandy & Gatch, 2009; 
Hernandez et al., 2014; Mendez et al., 2010; Simon Mendez, & Setlow, 2007; but 
see Broos et al., 2012a), as does chronic self-administration of amphetamine or 
heroin (Gipson & Bardo, 2009; Schippers et al., 2012).  Finally, withdrawal from 
phencyclidine increases impulsive choice (Carroll, Kohl, Johnson, & La Nasa, 
2013; Carroll, Mach, La Nasa, & Newman, 2009).  In conclusion, exposure to 
drugs of abuse increases impulsive decision making.  
Underlying Neuromechanisms Linking Impulsive Choice and Drug Abuse 
 Understanding the potential underlying neural mechanisms linking 
impulsive choice and drug reinforcement can help explain why HiI individuals are 
prone to drug abuse.  Such information is important for the development of better 
treatment options for individuals with substance use disorders.  
Neuroanatomical Regions Implicated in Impulsive Choice  
To identify the neuroanatomical structures involved in discounting, 
techniques such as focal excitotoxic or neurochemical lesions and temporary 
inactivation are often used.  Several brain regions have been implicated in 
impulsive choice, including amygdala (Churchwell, Morris, Heurtelou, & Kesner, 
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2009; Winstanley, Theobald, Cardinal, & Robbins, 2004b), dorsal striatum 
(Dunnett, Heuer, Lelos, Brooks, & Rosser, 2012), and hippocampus (Abela & 
Chudasama, 2013; Cheung & Cardinal, 2005; Mariano et al., 2009).  However, 
structures within the mesocorticolimbic pathway have received particular interest 
due to the major hypothesis that chronic drug exposure augments stimulus-
reward learning and impairs inhibitory control functions, facilitating relapse-like 
behavior (Jentch & Taylor, 1999; Robinson & Berridge, 2003).  This portion of the 
dissertation will focus on three regions within the mesocorticolimbic pathway: 
orbitofrontal cortex (OFC), medial prefrontal cortex (mPFC), and nucleus 
accumbens (NAc).  
Orbitofrontal cortex (OFC). OFC is implicated in various forms of 
decision making, most importantly in updating the value of an expected reward 
on the basis of past experience (Gallagher, McMahan, & Shoenbaum, 1999; 
Izquierdo, Suda, & Murray, 2004; Roesch & Olson, 2004; Schoenbaum, Chiba, & 
Gallagher, 1998; Schoenbaum, Setlow, & Ramus, 2003; see Wallis, 2007 for a 
review).  OFC also is implicated in drug abuse, as hypoactivity within this region 
is observed in individuals with cocaine addiction (Volkow et al., 1993, 1991) and 
re-exposure to a drug-paired context activates OFC in nonhuman animals 
(Hearing, Miller, See, & McGinty, 2008; Neisewander et al., 2000).  Lesions to 
OFC decrease cocaine self-administration in rats (Hutcheson & Everitt, 2003; but 
see Grakalic, Panlilio, Quiroz, & Schindler, 2010), and inactivation of OFC 
attenuates cue-induced cocaine seeking behavior (Fuchs, Evans, Parker, & See, 
2004).  
 
	  
	   16 
Studies examining the role of OFC in delay discounting behavior have 
produced variable results.  During performance in an adjusting-delay procedure, 
an increase in Fos expression in OFC is observed (de Costa Araújo et al., 2010).  
Also, several studies have found an increase in the rate of discounting following 
lesions to OFC (Mobini, Chiang, Ho, Bradshaw, & Szabadi, 2002; Kheramin et 
al., 2002, 2004; Rudebeck et al., 2006).  However, other studies have observed 
either a decrease in discounting (Mar, Walker, Theobald, Eagle, & Robbins, 
2011; Winstanley et al., 2004b) or no effect in discounting behavior following 
temporary inactivation via GABA agonists or permanent lesions (Abela & 
Chudasama, 2013; Churchwell et al., 2009; Jo, Kim, Lee, & Jung, 2013; Mariano 
et al., 2009; Stopper, Green, & Floresco, 2014).  These discrepancies may result 
from differential destruction of subregions of OFC, as lesions to medial OFC 
increase sensitivity to delayed reinforcement, whereas lesions to lateral OFC 
decrease discounting (Mar et al., 2011).  
Other methodogical factors that can potentially explain the discrepancies 
observed across studies include baseline levels of impulsive choice and cues 
that signal the delay to the larger reinforcer.  For example, inactivation of OFC 
increases impulsive choice in LoI rats when the delay is signaled, but decreases 
impulsivity in HiI rats when the delay is not signaled (Zeeb, Floresco, & 
Winstanley, 2010).  
Medial prefrontal cortex (mPFC). mPFC can be subdivided into 
prelimbic cortex (PrLC) and infralimbic cortex (ILC) and is involved in reward-
related learning (Balleine & Dickinson, 1998; Richardson & Gratton, 1998).  
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mPFC is implicated in the reinforcing effects of drugs of abuse, as well as drug 
relapse (see Perry et al., 2011; Tzschentke, 2000 for reviews).  
Some studies have shown that mPFC mediates delay discounting.  In 
humans, decreased impulsive choice is associated with increased thickness in 
mPFC (Bernhardt et al., 2014).  Also, impulsive choice is negatively correlated 
with mPFC activation (Antonelli et al., 2014).  In animals, mPFC inactivation 
increases sensitivity to delayed reinforcement (Churchwell et al., 2009), although 
whole mPFC lesions and ventral mPFC inactivation have no delay-specific 
effects on choice between small, immediate and large, delayed rewards 
(Cardinal, Pennicott, Sugathapala, Robbins, & Everitt, 2001; Feja & Koch, 2014).  
Nucleus accumbens (NAc). NAc is composed of the core (NAcc) and 
shell (NAcSh) subregions (Voorn, Gerfen, & Groenewgen, 1989; Zaborsky et al., 
1985) and responds to anticipated rewards (Bjork et al., 2004; Breiter, Aharon, 
Kahneman, Dale, & Shizgal, 2001; Francois, Conway, Lowry, Tricklebank, & 
Gilmour, 2012; Martin & Ono, 2000; Richardson & Gratton, 2008; Schultz, 
Apicella, Scarnati, & Ljungberg, 1992) and mediates the reinforcing effects of 
various drugs of abuse (see Chen, Hopf, & Bonci, 2010; Di Chiara, 2002; Di 
Chiara et al., 2004; Willuhn, Wanat, Clark, & Phillips, 2010 for reviews).  In 
general, lesions to NAc attenuate drug self-administration in animals (Corrigall, 
Franklin, Coen, & Clarke, 1992; Dworkin, Guerin, Goeders, & Smith, 1988; 
Gerrits & Van Ree, 1996).   
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Animals performing a delay discounting procedure show an increase in 
Fos expression in NAcc (da Costa Araújo et al., 2010).  Also, NAcc lesions 
increase impulsive choice (Bezzina et al., 2007; Cardinal et al., 2001; da Costa 
Araújo et al., 2009; Pothuzien, Jongen-Relo, Feldon, & Yee, 2005; Valencia-
Torres et al., 2012; but see Winstanley, Theobald, Dalley, & Robbins, 2005), 
whereas combined NAcc/NAcSh lesions increase preference for a large, delayed 
reinforcer (Acheson et al., 2006).  The findings obtained by Acheson et al. (2006) 
do not appear to be the result of damage to NAcSh, as selective lesions to this 
subregion do not alter sensitivity to delayed reinforcement (Pothuzien et al., 
2005).  
Neurochemical Systems Involved in Impulsive Choice 
Several techniques can be used to study the involvement of 
neurotransmitter systems in impulsive choice.  A common method for 
determining the role of a neurotransmitter in discounting behavior is to administer 
a drug that acts at specific receptors.  Typically, the drug is administered 
systemically, although receptor ligands can be directly injected into a brain region 
of interest.  Another technique that can be used is microdialysis, in which a 
neurotransmitter of interest is collected during task performance and later 
quantified.  Through these techniques, serotonin (5-HT) and dopamine (DA) 
systems have been implicated as important mediators of impulsive choice and 
will be discussed in detail below.  
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Serotonin (5-HT). 5-HT is a monoamine synthesized from tryptophan.  5-
HT released from a presynaptic neuron can bind to different receptor families, 
which are primarily G protein-coupled.  Currently, there are 14 known 5-HT 
receptor subtypes within 7 different families (see Barnes & Sharp, 1999; Filip & 
Bader, 2009 for full reviews).  For brevity, only the first three 5-HT receptor 
families will be discussed in detail.  5-HT1 receptors can be divided into five 
subtypes (5-HT1A,B,D,E,F) which are distributed throughout the brain, particularly in 
the raphe nuclei, hippocampus, cerebral cortex, and basal ganglia (Pazos & 
Palacios, 1985; Weissmann-Nanopoulos, Mach, Magre, Demassey, & Pujol, 
1985; Vergé et al., 1986).  5-HT1 receptors inhibit cyclic adenosine 
monophosphate (cAMP; Fargin et al., 1989) and are autoreceptors in the raphe 
nuclei and postsynaptic receptors in the limbic system (see Albert, Lembo, 
Storring, Charest, & Saucier, 1996; Barnes & Sharp, 1999).  5-HT2 receptors can 
be subdivided into three subtypes (5-HT2A-C), and like 5-HT1 receptors, are 
distributed throughout the brain, such as hippocampus, cortex, basal ganglia, 
amygdala, hypothalamus, and cerebellum (Bonhaus et al., 1995; Pazos, Cortes, 
& Palacios, 1985; Pazos, Probst, & Palacios, 1987).  5-HT2 receptors are 
coupled to phospholipase C and lead to increased inositol 1,4,5-trisphosphate 
and intracellular Ca2+ (Nakaki, Roth, Chuang, & Costa, 1985; Xu & Chuang, 
1987).  The 5-HT3 receptor is the only 5-HT receptor subtype that is a ligand-
gated ion channel (Derkach, Surprenant, & North, 1989) and is mainly located in 
limbic structures such as the hippocampus and amygdala (Tecott, Maricq, & 
Julius, 1993).  
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Low 5-HT activity has been linked to impulsive behavior, as individuals 
prone to suicide often display impulsive behavior and have decreased levels of 
the 5-HT metabolite 5-hydroxyindoleacetic acid (5-HIAA; Åsberg, 1997; 
Cremniter et al., 1999; Träskman-Bendz, Åsberg, & Schalling, 1986).  Forebrain 
5-HT depletion also increases impulsive decision making in humans 
(Schweighofer et al., 2008; but see Crean, Richards, & de Wit, 2002) and 
animals (Bizot et al., 1999; Mobini et al., 2000; Wogar, Bradshaw, & Szabadi, 
1993; but see Winstanley, Dalley, Theobald, & Robbins, 2003, 2004a). 
Pharmacological studies also support the role of 5-HT in delay discounting 
behavior, although discrepancies are reported in the literature.  Inhibiting the 
synthesis of 5-HT with para-chlorophenyl-alanine methyl ester increases 
impulsive choice in a T-maze paradigm (Denk et al., 2005).  The 5-HT indirect 
agonist fenfluramine decreases impulsive choice (Poulos, Parker, & Le, 1996), 
whereas 5-HT1A receptor agonists dose-dependently promote choice of the 
small, immediate reinforcer over the large, delayed reinforcer (Blasio et al., 2012; 
Liu, Wilkinson, & Robbins, 2004; Stanis et al., 2008; Winstanley et al., 2005).  5-
HT1A receptor agonists also decrease choice for the larger reinforcer when the 
delay to its delivery is set at 0 sec (Liu et al., 2004; Winstanley et al., 2005); thus, 
sensitivity to reinforcer magnitude may be altered, as well as sensitivity to delay.  
Stimulating 5-HT2A/C receptors decreases the capacity for rats to wait for 
delivery of a large magnitude reinforcer (Blasio et al., 2012; Hadamitzky, Feja, 
Becker, & Koch, 2009), whereas antagonism of these receptors does not alter 
discounting behavior (Hadamitzky et al., 2009; Paterson, Wetzler, Hackett, & 
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Hanania, 2012; Talpos, Wilkinson, & Robbins, 2006).  Conversely, antagonism of 
5-HT2B/C receptors decreases impulsive choice (Paterson et al., 2012; Talpos et 
al., 2006).  
 There is limited evidence that 5-HT3 receptors are involved in impulsive 
choice.  Administration of the 5-HT3 receptor antagonist tropisetron decreases 
impulsive choice in animals with high baseline levels of impulsivity, whereas 
tropisetron increases impulsive choice in animals with low baseline levels of 
impulsivity (Cervantes, Biggs, & Delville, 2010).  
Stereotaxic techniques show that 5-HT within the mesocorticolimbic 
pathway is involved in impulsive decision making.  Using in vivo microdialysis, 
performance in delay discounting significantly increases 5-HT efflux in mPFC 
(Winstanley, Theobald, Dalley, Cardinal, & Robbins, 2006b).  Furthermore, 
microinjection of 5-HT2A/C receptor antagonists into the OFC increases impulsive 
choice (Wischhof, Hollensteiner, & Koch, 2011), whereas 5-HT1A receptor 
agonists into the OFC decreases impulsive choice (Yates et al., under review).  
Finally, HiI animals have increased 5-HT3 receptor expression in amygdala, 
prefrontal cortex (PFC), and NAc (Cervantes, & Delville, 2009).  Taken together, 
the results of these studies indicate that 5-HT mediates impulsive decision 
making.  
Dopamine (DA). DA belongs to the catecholamine family and is 
synthesized from the amino acid tyrosine.  DA released from a presynaptic 
neuron can bind to two different types of DA receptors: D1-like and D2-like.  D1-
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like receptors (D1 and D5) are located on postsynaptic neurons, are G protein-
coupled (Gs), and increase cAMP levels (Dearry et al., 1990; Sunahara et al., 
1991; Tiberi et al., 1991).  D1 receptors are primarily located in the striatum, NAc, 
cortex, olfactory tubercle, amygdala, and hippocampus (Dearry et al., 1990; 
Savasta, Dubois, & Scatton, 1986), whereas D5 receptors are primarily located in 
the olfactory tubercle and hippocampus, although these receptors are observed 
in other regions, such as striatum, NAc, and cortex (Ciliax et al., 2000; Sunahara 
et al., 1991).  
Like D1-like receptors, D2-like receptors (D2, D3, and D4) are G protein-
coupled (Gi); however, these receptors are located on both presynaptic and 
postsynaptic neurons and decrease cAMP when stimulated (Dal Toso et al., 
1989).  D2 receptors are primarily located in the striatum, NAc, olfactory tubercle, 
amygdala, hippocampus, hypothalamus, ventral tegmental area, and substantia 
nigra (Camus, Javoy-Aqid, Dubois, & Scatton, 1986; Charuchinda, Supavilai, 
Karobath, & Palacios, 1987).  D3 receptors are located in the nucleus 
accumbens, hypothalamus, and olfactory tubercle (Bouthenet et al., 1991; 
Sokoloff, Giros, Martres, Bouthenet, Schwartz, 1990).  D4 receptors are located 
in the cortex, amygdala, hypothalamus, hippocampus, and substantia nigra 
(O’Malley, Harmon, Tang, & Todd, 1992; Wedzony, Chocyk, Maćkowiak, Fijał, & 
Czyrak, 2000).  
The role of DA in delay discounting is of particular interest because many 
drugs of abuse, as well as medications used to treat impulse-control disorders 
(e.g., ADHD; see Biederman & Faraone, 2005 for a review), increase 
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extracellular DA levels (Caillé & Parsons, 2003; Creese & Iverson, 1975; Jones, 
Gainetinov, Wightman, & Caron, 1998; Kuczenski & Segal, 1997; Moghaddam & 
Bunney, 1989; Volkow, Fowler, Wang, Ding, & Gatley, 2002).  As expected, 
psychostimulant medications such as amphetamine and methylphenidate 
decrease impulsive choice (e.g., Broos et al., 2012a; Cardinal, Robbins, & 
Everitt, 2000; de Wit et al., 2002; Pitts & McKinney, 2005; van Gaalen, van 
Koten, Schoffelmeer, & Vanderschuren, 2006b; Winstanley et al., 2003).  
Based on the findings observed with ADHD medications, drugs that 
stimulate DA neurotransmission should decrease impulsive choice, whereas 
drugs that inhibit DA release should increase impulsive choice.  More specifically, 
drugs that stimulate postsynaptic D1-like receptors or inhibit presynaptic D2-like 
receptors should decrease impulsivity, whereas inhibiton of D1-like receptors and 
stimulation of D2-like autoreceptors should increase impulsivity.  There is some 
support for this hypothesis, as systemic administration of the nonselective DA 
receptor antagonist flupenthixol (Cardinal et al., 2000; Floresco, Tse, & Ghods-
Sharifi, 2008; Wade, de Wit, & Richards, 2000), as well as selective antagonism 
of D1 receptors promote impulsive choice (Broos et al., 2012a; Koffarnus, 
Newman, Grundt, Rice, & Woods, 2011; van Gaalen et al., 2006b; but see Wade 
et al., 2000).  However, contrary to the hypothesis that DA stimulation decreases 
impulsive choice, systemic administration of D1-like receptor agonists do not 
alter delay discounting (Koffarnus et al., 2011).  
Research examining the role of DA D2-like receptors has yielded mixed 
results.  A couple of reports found increases in impulsive choice following 
 
	  
	   24 
antagonism of D2-like receptors (Denk et al., 2005; Wade et al., 2000), whereas 
others did not observe changes in delay discounting (Evenden & Ryan, 1996; 
Koffanus et al., 2011; van Gaalen et al., 2006b).  Considering that D2-like 
receptors are composed of three subtypes, perhaps D3 and D4 receptors have a 
more specific role in mediating impulsive decision making.  Administration of the 
D3 agonist 7-OH-DPAT and the D4 partial agonist ABT-724 increase delay 
discounting (Koffarnus et al., 2011; van den Bergh, Bloemarts, Groenink, Olivier, 
& Oosting, 2006).  However, it is important to note that administration of D3 
receptor agonists do not necessarily affect sensitivity to delayed reinforcement, 
as choice for the large reinforcer decreases when its delivery is immediate 
(Koffarnus et al., 2011; Madden, Johnson, Brewer, Pinkston, & Fowler, 2010; van 
den Bergh et al., 2006).  
DA activity specifically in prefrontal cortical regions has been associated 
with impulsive choice.  Using microdialysis, an increase in intra-OFC 3,4-di-
hydroxyl-phenylacetic acid (DOPAC) is observed in rats performing a delay 
discounting task (Winstanley et al., 2006b).  HiI rats show reduced DA release in 
mPFC and NAc relative to LoI rats (Diergaarde et al., 2008).  Depleting DA levels 
in mPFC also increases impulsive decision making (Loos et al., 2010; Pardey et 
al., 2013), and overexpression of the DA transporter (DAT) gene in NAc is 
associated with increased impulsive choice (Adriani et al., 2009).  As with 
systemic drug administration, one unexpected finding is that antagonism of DA 
D2-like receptors within OFC and mPFC increases impulsive choice (Pardey, 
Kumar, Goodchild, & Cornish, 2013; Yates et al., under review; Zeeb et al., 2010) 
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and administration of a D1-like agonist into mPFC increases impulsive choice 
(Loos et al., 2010).  Thus, while some inconsistencies exist, results overall 
suggest that decreased DA levels is associated with increased impulsive choice.  
In addition to DA specifically, Winstanley et al. (2005) argue that 5-HT and 
DA interactions within NAc contribute to impulsive decision making.  For 
example, the 5-HT1A agonist 8-OH-DPAT decreases choice for a large, delayed 
reinforcer; however, this effect is not observed in rats with intra-NAc 6-
hydroxydopamine lesions (Winstanley et al., 2005).  The results obtained by 
Winstanley et al. (2005) are difficult to interpret because 8-OH-DPAT decreases 
choice for the large reinforcer when its delivery is not delayed.  Therefore, DA 
and 5-HT interactions within NAc may be important for discriminating reinforcers 
of differing magnitudes, as opposed to discriminating delays to reinforcement.  
Although 5-HT and DA have received considerable attention in delay 
discounting research, there is evidence that other neurotransmitter systems are 
important in mediating impulsive decision making, including norepinephrine 
(Robinson et al., 2008; van Gaalen et al., 2006b), acetylcholine (specifically 
muscarinic receptors; Mendez, Gilbert, Bizon, & Setlow, 2012), opioid peptides 
(Pattij, Schetters, Janssen, Wiskerke, & Schoffelmeer, 2009; Schippers et al., 
2012), and glutamate (Glu; Cottone et al., 2013; Floresco et al., 2008; Sukhotina 
et al., 2008). Thus, multiple neurotransmitter systems working in an interactive 
fashion are involved in impulsive choice. 
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Glutamate (Glu).  Glu is the major excitatory neurotransmitter in the 
mammalian brain and acts at both metabotropic (mGluR, G protein-coupled) and 
ionotropic receptors (iGluR, ion channel-coupled; see Ozawa, Kamiya, & 
Tsuzuki, 1998 for a review).  mGluRs can be subdivided into three classes: group 
I mGluRs consists of mGluR1 and mGluR5, which are located on postsynaptic 
terminals and are stimulatory; in contrast, group II and group III mGluRs consist 
of mGluR2-8, which are mainly presynaptic and are inhibitory (Ozawa et al., 
1998; Riedel, Platt, & Micheau, 2003).  Like mGluRs, iGluRs can be subdivided 
into three groups: α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA), 
kainate, and N-methyl-D-aspartate (NMDA), which are discussed in more detail 
below.  
AMPA receptors are tetramers composed of four subunits (GluR1-4) and 
are found ubiquitously throughout the brain, with high levels observed in the CA1 
and CA3 regions of the hippocampus, as well as cerebral cortex, basal ganglia, 
thalamus, hypothalamus, cerebellum, and spinal cord (Blackstone et al., 1992; 
Dure & Young, 1995; see Ozawa et al., 1998; Riedel et al., 2003 for reviews).  
Activation of AMPA receptors increases Na+ and Ca2+ influx and K+ efflux (see 
Forman, Chou, Strichartz, & Lo, 2008 for a discussion), and these receptors are 
responsible for the fast, immediate postsynaptic response to glutamate release 
(see Riedel et al., 2003).  Like AMPA receptors, kainate receptors are tetramers 
composed of various subunits (GluR5-7 and KA1-2), with high levels located in 
the CA3 region of the hippocampus and in the cerebellum (see Ozawa et al., 
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1998).  Because dissociating AMPA and kainate receptors can be difficult, these 
receptors are often labeled as “non-NMDA” receptors (see Riedel et al., 2003).    
NMDA receptors are heteromeric complexes with the NR1 as the primary 
constitutive subunit and NR2 (A-D) as functional subunits that affect channel 
kinetics and sensitivity (Mori & Mishina, 1995).  Individual subunits are trafficked 
to synapses and can be substituted with one another.  For example, NR2B-
containing receptors can be replaced by NR2A-containing receptors (Barria & 
Malinow, 2002).  Like non-NMDA receptors, NMDA receptors are found 
throughout the brain, with the highest concentrations observed in the CA1 region 
of the hippocampus, thalamus, and cerebral cortex (see Ozawa et al., 1998; 
Riedel et al., 2003).  The NMDA receptor channel will open following voltage 
dependent removal of a Mg2+ ion (Novak Bregestovski, Ascher, Herbet, & 
Prochiantz, 1994), glycine binding to the NR1 subunit, and binding of Glu or 
NMDA receptor agonist to the NR2 subunit (see Lynch & Guttmann, 2001; 
Ozawa et al., 1998 for reviews).  Once the channel opens, Na+ and Ca2+ are able 
to enter the neuron, and there is an increase in K+ efflux (see Riedel et al., 2003).  
There is evidence that the glutamatergic system interacts with monoamine 
neurotransmitters.  Stimulation of 5-HT1 receptors inhibits Glu release (Choi, 
Cho, & Jang, 2013; Guo & Rainnie, 2010; Mauler, Fahrig, Horváth, & Jork, 2001). 
Furthermore, there is evidence that 5-HT1B and 5-HT1D receptors are 
heteroreceptors on glutamate neurons, which control the release of Glu (see 
Sari, 2013 for a discussion).  There is speculation that 5-HT2A regulates 
presynaptic release of Glu.  For example, lysergic acid diethylamide (LSD) 
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increases Glu levels in PFC, an effect that is blocked by a selective 5-HT2A 
antagonist (Muschamp, Regina, Hull, Winter, & Rabin, 2004).  Glu is proposed to 
modulate the release of DA, as stimulation of NMDA receptors within PFC 
decreases DA release in the same region (Del Arco & Mora, 2001).  
Furthermore, antagonism of NMDA receptors within PFC increases DA levels 
within NAc (Del Arco, Segovia, & Mora, 2008).  
Glutamatergic activity is important in learning (see Riedel et al., 2003 for a 
comprehensive review), and is hypothesized to be abnormal in several 
psychiatric conditions, including ADHD (MacMaster, Carrey, Sparkes, & 
Kusumakar, 2003).  Also, evidence suggests a role for Glu in the initiation, 
maintenance, and relapse of abuse-related behaviors (see Kalivas, 2009 for a 
review).  
Some evidence suggests a role for Glu in impulsive choice.  Antagonism 
of mGluR1 receptors decreases sensitivity to delayed reinforcement (Sukhotina 
et al., 2008).  Furthermore, administration of the mGluR2/3 receptor agonist 
LY379268 attenuates 5-HT2A-induced impulsive choice, although administration 
of LY379268 alone does not alter discounting (Wischof et al., 2011).  Blockade of 
NMDA receptors with the noncompetitive antagonists ketamine and/or 
memantine increase impulsive choice (Cottone et al., 2013; Floresco et al., 2008; 
but see Oberlin, Bristow, Heighton, & Grahame, 2010).  However, interpreting the 
results obtained by Cottone et al. (2013) and Floresco et al. (2008) is difficult 
because ketamine and memantine inhibit 5-HT receptors (Kapur & Seeman, 
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2002; Rammes, Rupprecht, Ferrari, Zieglgänsberger, & Parsons, 2001).  Overall, 
more work is needed to elucidate the role of Glu in impulsive choice.  
Overview of the Current Experiments 
Due to the complexity of impulsive decision making, there is a need to 
elucidate the underlying neuromechanisms of this facet of impulsivity.  
Understanding the precise role of Glu and DA in this behavior may shed light as 
to why increased impulsive choice is a predictor and consequence of substance 
use disorders.  Although NAcc is consistently shown to mediate impulsivity, it is 
unclear which neurotransmitters within this region are involved in discounting.  
Thus, the overall goal of the current experiments was to elucidate the role of 
NAcc glutamatergic and dopaminergic systems in mediating impulsive choice.  
 Studies using systemic drug administration have examined the role of DA 
receptors in discounting performance.  Although there are some discrepancies, 
findings generally support the hypothesis that increasing DA levels decreases 
impulsive decision making.  However, the role of Glu in delay discounting is not 
as clear.  Therefore, Experiment 1 was conducted to further clarify the role of 
ionotropic Glu receptors in impulsive decision making.  The effects of the 
noncompetitive NMDA channel blocker MK-801 and the AMPA receptor 
antagonist 6-cyano-7-nitroquinoxaline-2,3-dione disodium salt hydrate (CNQX) 
on delay discounting performance were examined.  It was hypothesized that 
blocking NMDA and AMPA receptors would increase impulsive choice.  
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  Experiment 2 was conducted to determine if NMDA receptor and 
dopamine transporter expression differed in HiI and LoI animals.  DAT was 
selected because drugs used to treat impulse control disorders exert their 
therapeutic effects by blocking DAT (see Biederman & Faraone, 2005 for a 
review).  The hypothesis was that high impulsive animals would have decreased 
NMDA receptor, but increased DAT, expression within NAcc relative to low 
impulsive animals.  
 The goal of Experiment 3 was to determine the role of NAcc NMDA and 
DA receptors in mediating impulsive choice.  Furthermore, the goal was to 
determine if NR2B containing NMDA receptors are important for controlling 
impulsive choice.  One group of rats received intra-NAcc bilateral infusions of the 
Glu-selective ligands MK-801, AP-5 (NMDA competitive antagonist), ifenprodil 
(NR2B antagonist), and CNQX.  Another group of rats received the DA D1-like 
ligands SKF 38393 (agonist) and SCH 23390 (antagonist) and the DA D2-like 
ligands quinpirole (agonist) and eticlopride (antagonist).  There were two major 
hypotheses.  First, antagonism of NMDA receptors, specifically NR2B containing 
receptors, would decrease impulsive choice.  Second, antagonism of D1-like and 
D2-like receptors would increase impulsive choice.  
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Chapter 2: Experiment 1 
Introduction  
 Although evidence shows that 5-HT and DA receptors are involved in 
impulsive choice (e.g., Cardinal et al., 2000; Floresco et al., 2008; Koffarnus et 
al., 2011; Liu et al., 2004; van Gaalen et al., 2006b; Winstanley et al., 2005), the 
specific role of iGluRs in this task is unknown.  Some evidence suggests that 
blockade of NMDA receptors with the noncompetitive antagonists ketamine and 
memantine increase impulsive choice (Cottone et al., 2013; Floresco et al., 
2008).  However, ketamine and memantine interact with 5-HT receptors (Kapur & 
Seeman, 2002; Rammes et al., 2001), thus complicating the results of these 
studies.  This study was performed to further clarify the role of NMDA receptors 
in impulsive choice by testing the effects of the noncompetitive NMDA receptor 
antagonist MK-801 in delay discounting.  To determine the potential role of 
AMPA receptors in delay discounting, a subset of rats were treated with the 
AMPA receptor antagonist CNQX.      
Materials and Methods 
Animals 
 Twelve male Sprague Dawley rats were obtained from Harlan Industries 
(Indianapolis, IN).  They were acclimated to a colony room held at a constant 
temperature and handled for 5 days upon arrival.  Rats had no prior operant 
training before the current experiment; however some were treated with 
amphetamine (1.0 mg/kg; 4 injections) or saline (4 or 8 injections) during 
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adolescence in a previous experiment.  Amphetamine treatment during 
adolescence did not significantly alter discounting of delayed or probabilistic 
reinforcement in the current study (data not shown).  Rats were individually 
housed during the current experiment.  Light and dark phases were on a 12:12 h 
cycle, and all experiments occurred in the light phase.  Rats were food restricted 
(approximately 80% of free feed body weight) during behavioral studies.  All 
procedures were in accordance with the “Guide for the Care and Use of 
Laboratory Animals” (National Research Council, 2011) and were approved by 
the Institutional Animal Care and Use Committee at the University of Kentucky.  
Drugs 
(+)-MK-801 hydrogen maleate and 6-cyano-7-nitroquinoxaline-2,3-dione 
disodium salt hydrate (Sigma, St. Louis, MO) were prepared in sterile 0.9% NaCl 
(saline) and subcutaneously injected in a volume of 1 ml/kg.  The doses were 
calculated based on salt weight.    
Apparatus  
 Operant conditioning chambers (28 × 21 × 21 cm; ENV-008; MED 
Associates, St. Albans, VT) located inside sound-attenuating chambers (ENV-
018M; MED Associates) were used.  The front and back walls of the 
experimental chambers were made of aluminum, while the side walls were made 
of Plexiglas.  There was a recessed food tray (5 x 4.2 cm) located 2 cm above 
the floor in the bottom-center of the front wall.  An infrared photobeam was used 
to record headentries into the food tray. A 28-V white cue light was located 6 cm 
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above each response lever.  A white houselight was mounted in the center of the 
back wall of the chamber.  All responses and scheduled consequences were 
recorded and controlled by a computer interface.  A computer controlled the 
experimental session using Med-IV software. 
Procedure  
Rats were given 2 days of magazine training, in which sucrose-based 45 
mg pellets (F0021 dustless precision pellet, Bio-Serve, Frenchtown, NJ) were 
noncontingently delivered into the food tray.  These sessions were used to 
habituate rats to the operant chamber. Following magazine training, rats were 
given lever press training.  Each session began with illumination of the 
houselight.  A head entry into the food hopper resulted in presentation of one 
lever.  Levers were presented semi-randomly, with no more than two consecutive 
presentations of the same lever.  A response on either lever resulted in delivery 
of one sucrose pellet.  Pellets were also delivered noncontingently on a random 
time 100-sec schedule of reinforcement.  Following a response on either lever, 
the houselight was extinguished, and the lever was retracted for 5 sec.  After 5 
sec, the houselight was illuminated.  Each session lasted 30 min.  
 After 3 sessions, rats received reward magnitude discrimination training, 
which consisted of 40 trials.  Each trial lasted 40 sec and began with illumination 
of the houselight.  A headentry into the food hopper extended one of the levers 
(semi-randomly presented, with no more than two consecutive presentations of 
the same lever).  A response on one lever resulted in immediate delivery of one 
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pellet, whereas a response on the other lever resulted in immediate delivery of 
four pellets (the lever associated with the large reward magnitude was 
counterbalanced across rats).  Following a response, the houselight was 
extinguished, and the lever was retracted for the remainder of the trial.  If a 
response was not made within 10 sec, the trial was scored as an omission, and 
the houselight was extinguished for the remainder of the trial.  After 7 days of 
reward magnitude discrimination training, rats were trained in a delay discounting 
task.    
 Delay discounting sessions consisted of 5 blocks of 9 trials, and each trial 
lasted 60 sec.  The first 4 trials in a block were forced-choice trials, in which only 
one lever was semi-randomly presented (no more than 2 consecutive 
presentations of the same lever).  The last 5 trials were free-choice trials, in 
which both levers were extended.  As in reward magnitude discrimination 
training, a response on one lever always resulted in immediate delivery of one 
food pellet.  A response on the other lever resulted in delivery of 4 pellets; 
however, the delay to the delivery of the large magnitude reward increased 
across blocks of trials (0, 5, 10, 20, 50 sec).  Following a response on either 
lever, the houselight was extinguished, and the lever was retracted for the 
remainder of the trial.  If a response was not made within 10 sec, the trial was 
scored as an omission, and the houselight was extinguished for the remainder of 
the trial.  
 After training, rats received various doses of the NMDA receptor 
antagonist MK-801 (0, 0.01, 0.03, 0.1, or 0.3 mg/kg, s.c.) 15 min prior to the 
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session.  The doses and pretreatment time were chosen based on previous work 
(Almasi-Nasrabadi et al., 2012; Fredriksson & Archer, 2002; Wooters, Dwoskin, 
& Bardo, 2011).  A subset of rats (n = 6) received additional training in the delay 
discounting task before receiving various doses of the AMPA receptor antagonist 
CNQX (0, 1, 3, or 5.6 mg/kg, i.p.) 20 min prior to the session.  The doses and 
pretreatment time were chosen based on previous work (Bäckström & Hyytiä, 
2004; Wooters et al., 2011).  In each experiment, pretreatments occurred once 
every 4 days, and dose order was randomized.  
Statistical Analyses 
To determine if MK-801 or CNQX altered delay discounting, two analyses 
were used.  First, the hyperbolic discounting function was used and was defined 
with the equation V = A/(1+kX), where V is the subjective value of the reinforcer, 
A is reinforcer amount, k is the rate of discounting, and X represents the delay to 
reinforcer delivery (Mazur, 1987).  Second, area under the curve (AUC) was 
calculated as previously described (Myerson et al., 2001).  The delay and 
subjective value for each data point were first normalized.  Delay was expressed 
as a proportion of the maximum delay, and the subjective value was expressed 
as a proportion of the nominal amount.  These normalized values were used as x 
coordinates and y coordinates, respectively, to construct a graph of the 
discounting data.  Vertical lines were drawn from each data point to the x axis, 
subdividing the graph into a series of trapezoids.  The area of each trapezoid is 
equal to (x2 – x1)[(y1 + y2)/2], where x1 and x2 are successive delays, and y1 and 
y2 are the subjective values associated with these delays.  The area under the 
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discounting function is equal to the sum of the areas of these trapezoids.  AUC 
values range from 0 to 1, with values closer to 0 indicating steeper discounting 
and values closer to 1 representing shallower discounting.  
K parameter estimates (log transformed) and AUCs were analyzed with 
repeated measures analyses of variance (ANOVA), with treatment as a within-
subjects factor.  Main effects were probed with Bonferroni post hoc tests.  
Cohen’s f was calculated as a measure of effect size, with 0.10, 0.25, and 0.40 
defined as small, medium, and large, respectively (Cohen, 1988).  Because 
omissions and A parameter estimates were not normally distributed, these data 
were analyzed with Friedman tests.  Main effects were probed with Wilcoxon 
signed-ranked post hoc tests.  Startisitical significance was defined as p < .05 in 
all cases, except for the use of Wilcoxon signed-ranked post hoc test, in which a 
Bonferroni adjustment was used to correct for multiple comparisons.  
Results 
Figure 2.1 shows the proportion of choices for the delayed reinforcer 
following all doses of MK-801 (Figure 2.1A) and CNQX (Figure 2.1B).  The 
proportion of choices for the large delayed reinforcer decreased as function of 
the delay to receiving reinforcement, although the highest doses of MK-801 (0.1 
and 0.3 mg/kg) flattened the discounting function.  The flattening of the 
discounting function following MK-801 (0.1 and 0.3 mg/kg) can be attributed to a 
loss in schedule control, as these doses significantly increased omissions (χ2(2) = 
41.02, p < .05; Figure 2.2A).  The highest dose of MK-801 (0.3 mg/kg) disrupted 
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behavior across all blocks of trials, whereas the 0.1 mg/kg dose suppressed 
behavior in the first three blocks of delay discounting (data not shown).  Because 
the higher doses of MK-801 produced a general suppression in behavior, 
hyperbolic discounting functions could not be generated for all animals; thus, 
these doses were excluded from subsequent analyses of parameters A and k, as 
well as AUC.  CNQX did not significantly alter omissions (Figure 2.2B), so each 
dose (1, 3, 5.6 mg/kg) was included in all subsequent analyses.  
Parameters k and A were derived and plotted in Figure 2.3 and Figure 2.4, 
respectively, for each drug dose, except for the two highest doses of MK-801 (0.1 
and 0.3 mg/kg).  MK-801 (0.03 mg/kg) decreased sensitivity to delayed 
reinforcement (F(2, 22) = 5.04, p < .05, Cohen’s f = .67; Figure 2.3A).  The 
overall nonparametric analysis indicated that MK-801 also increased sensitivity to 
reinforcer magnitude in the delay discounting task (χ2(2) = 7.64, p < .05); 
however, post hoc tests revealed no significant differences between doses (p’s > 
.025, Bonferroni correction; Figure 2.4A).  CNQX did not alter sensitivity to 
delayed reinforcement (Figure 2.3B) or reinforcer magnitude (Figure 2.4B).  
Figure 2.5 shows AUCs for each drug dose, except for the highest dose of 
MK-801 (0.3 mg/kg; this dose was excluded because AUCs were virtually 0 for 
all animals).  Repeated measures ANOVA revealed that MK-801 (0.03 mg/kg) 
significantly increased AUCs (F(2, 22) = 6.35, p < .01, Cohen’s f = .77; Figure 
2.5A), whereas CNQX did not significantly alter AUCs (Figure 2.5B). 
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Discussion  
There were two important findings from the current experiment.  First, 
NMDA receptor blockade with MK-801 dose-dependently decreased sensitivity to 
delayed reinforcement.  The decrease in sensitivity occurred at a dose of MK-801 
(0.03 mg/kg) that did not alter omissions, suggesting a specific effect on choice 
behavior.  Second, AMPA receptor blockade did not alter sensitivity to delayed 
reinforcement.  Together, these results demonstrate a differential involvement of 
NMDA and AMPA receptors in delay discounting, with NMDA receptors playing a 
more critical role.  
The current results show that the non-competitive NMDA receptor 
antagonist MK-801 decreases sensitivity to delayed reinforcement (k parameter).  
This finding contrasts with previous studies showing that the non-competitive 
antagonists ketamine and memantine increase delay discounting (Cottone et al. 
2013; Floresco et al. 2008).  However, in addition to the different NMDA 
antagonists used, a number of methodological differences exist which prevent 
direct comparisons across studies.  For example, in contrast to the current study, 
Cottone et al. (2013) used an adjusting delay procedure, whereas the current 
study used a progressive discounting procedure derived from Evenden and Ryan 
(1996).  Interpreting results from the adjusting delay procedure used by Cottone 
et al. (2013) is difficult because the dependent variable confounds sensitivity to 
delayed reinforcement and reinforcer magnitude, which are proposed to 
independently influence discounting of a reinforcer (Ho, Mobini, Chiang, 
Bradshaw, & Szabadi, 1999).  Additionally, there is evidence to suggest that 
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animals trained in an adjusting delay procedure may not be sensitive to the 
adjusting delay to reinforcement (Cardinal et al., 2002).  Although Floresco et al. 
(2008) used a similar discounting procedure as the current study, a maximum 
delay of 6.5 sec was imposed, which is considerably shorter than the maximum 
delay used in the current study (50 sec).  Importantly, ketamine administration 
produced a parallel negative shift in the discounting curve at each delay, 
suggesting that sensitivity to reinforcer magnitude, but not the rate of discounting, 
was altered.  Future studies employing discounting functions may be better 
suited to determine the effect of various drug treatments on sensitivity to 
reinforcer amount and/or sensitivity to delayed reinforcement within discounting 
tasks.  
Beyond these methodological differences, an important pharmacological 
consideration for comparing results across studies is that MK-801, ketamine, and 
memantine show differential selectivity for non-NMDA receptors.  For example, in 
contrast to MK-801, ketamine acts at sigma receptors (Robson, Elliott, 
Seminerio, & Matsumoto, 2012) and opioid receptors (Gupta, Devi, & Gomes, 
2011).  Similarly, in contrast to MK-801, memantine reduces the physical signs of 
opiate withdrawal (Maldonado, Cauli, Rodriguez-Arias, Aguilar, & Minarro, 2003).  
Ketamine also acts as an antagonist at 5-HT2 receptors (Kapur & Seeman, 
2002), and memantine blocks 5-HT3 receptors (Rammes et al., 2001), although 
antagonism of 5-HT receptors typically does not increase the rate of discounting 
(Hadamitzky et al., 2009; Liu et al., 2004; Talpos et al., 2006).  MK-801 also has 
non-NMDA activity, as it inhibits nicotinic acetylcholine receptors (Amador & 
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Dani, 1991; Briggs & McKenna, 1996); however, blockade of nicotinic receptors 
does not alter discounting of delayed reinforcement (Mendez et al., 2012).   
Another important consideration is that memantine and MK-801 block 
NMDA receptor channels in different ways and show differential affinity for 
synaptic and extrasynaptic NMDA receptors.  Specificially, memantine reduces 
NMDA receptor-mediated excitatory postsynaptic potentials in a voltage-
dependent manner, whereas the effects of MK-801 on postsynaptic potentials 
appear to be less voltage-dependent (Frankiewicz, Potier, Bashir, Collingridge, & 
Parsons, 1996).  Furthermore, memantine shows fast blocking and unblocking 
kinetics, whereas MK-801 shows slow blocking and unblocking kinetics (see 
Danysz, Parsons, Kornhuber, Schmidt, & Quack, 1997 for a review).  Finally, 
memantine preferentially blocks extrasynaptic NMDA receptors, whereas MK-
801 blocks extrasynaptic and synaptic NMDA receptors (Xia et al., 2010).  Thus, 
the different pharmacological profiles of memantine and MK-801 may account for 
the differential effects observed in delay discounting.  
As for DA activity, previous work has shown that acute administration of 
MK-801 (0.03 and 0.1 mg/kg) increases DA levels in PFC (Tsukada et al., 2005).  
Interestingly, drugs that increase DA levels typically decrease sensitivity to 
delayed reinforcement (Broos et al., 2012a; Cardinal et al., 2000; de Wit et al., 
2002; Pitts & McKinney, 2005; van Gaalen et al., 2006b; Winstanley et al., 2003).  
Thus, the decrease in discounting observed following MK-801 administration 
might be explained from its interaction with the prefrontal DA system.  
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Interpreting AUCs can be problematic because this measure does not 
take into consideration sensitivity to reinforcer magnitude.  For example, AUCs 
for MK-801 (0.1 mg/kg) and vehicle did not differ significantly, which might 
suggest that MK-801 did not alter task performance at this dose.  However, 0.1 
mg/kg MK-801 flattened the discounting curve, demonstrating a general 
disruption in task performance at the 0 sec delay.  Overall, these results show 
that AUCs do not always describe discounting performance accurately when 
sensitivity to reinforcer magnitude is altered.   
 In conclusion, results from the current study show that NMDA and AMPA 
receptors differentially mediate discounting of delayed reinforcement.  Blockade 
of NMDA receptors with the non-competitive antagonist MK-801 decreased 
sensitivity to delayed reinforcement, whereas antagonism of AMPA receptors 
with CNQX did not alter delay discounting.  Understanding the precise role of 
glutamate systems might be beneficial in developing treatments for disorders 
characterized by increased impulsivity, such as drug abuse. 
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Figure 2.1. Mean (± SEM) proportion of choices for the large magnitude 
reinforcer as a function of the delay to receiving reinforcement following 
pretreatments with MK-801 (Panel A) and CNQX (Panel B).  
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Figure 2.2. Mean (± SEM) omissions during free-choice trials following 
pretreatments with MK-801 (A) and CNQX (B).  *p < .05, relative to vehicle.  
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Figure 2.3. Mean (± SEM) parameter estimate k values (log transformed) 
following pretreatments with MK-801 (A) and CNQX (B).  *p < .05, relative to 
vehicle. 
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Figure 2.4. Mean (± SEM) parameter estimate A values following pretreatments 
with MK-801 (A) and CNQX (B). 
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Figure 2.5. Mean (± SEM) area under the curve (AUC) values following 
pretreatments with MK-801 (A) and CNQX (B).  *p < .05, relative to vehicle.  Note 
that MK-801 (0.1 mg/kg) is not connected to the line in the graph because this 
dose was not used in analyses due to the large increase in omissions. 
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Chapter 3: Experiment 2 
Introduction  
The results from Experiment 1 showed that blockade of NMDA receptors 
with MK-801 decreased impulsive choice.  However, it is unknown if NMDA 
receptor densities are altered in animals that show differential sensitivity to 
delayed reinforcement.  Therefore, the goal of the present experiment was to use 
in vitro receptor autoradiography to quantify NMDA receptor density in the NAcc.  
This region was chosen because it has been consistently shown to be involved in 
impulsive choice (Bezzina et al., 2007; Cardinal et al., 2001; da Costa Araújo et 
al., 2009; Valencia-Torres et al., 2012), and NAcc NMDA receptors play a critical 
role in addiction (see Kalivas, 2009 for a review).  Because damage to the 
NAcSh does not alter delay discounting (Pothuzien et al., 2005), this region was 
examined as a negative control.   
A secondary goal of the present experiment was to determine if DAT is 
altered in HiI and LoI impulsive rats.  DAT was also examined because 
psychostimulant medications exert their therapeutic effects by blocking DAT (see 
Biederman & Faraone, 2005 for a review).  Furthermore, there is evidence that 
overexpression of DAT within NAc leads to increased impulsive decision making 
in a delay discounting task (Adriani et al., 2009).  The hypothesis for this 
experiment was that HiI animals would have decreased NMDA receptor, but 
increased DAT, expression within NAcc relative to LoI animals.  
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Materials and Methods 
Animals 
 A total of 24 experimentally naïve (i.e., have not received any 
pharmacological treatments) male, Sprague Dawley rats were obtained from 
Harlan Industries (Indianapolis, IN).  Rats weighed approximately 250-275 g 
upon arrival to the laboratory and were housed individually.  Rats were 
acclimated to a colony room held at a constant temperature and were handled for 
5 days upon arrival.  Light and dark phases were on a 12:12 h cycle, and all 
experiments occurred during the light phase.  Rats were food restricted 
(approximately 80% of free feed body weight) 3 days before the beginning of 
behavioral training, and rats remained on food restriction during the remainder of 
the study, unless otherwise noted.  
Apparatus 
 The apparatus was the same as described in Experiment 1.  
Procedure 
 Pre-training was similar to the training described in Experiment 1, with one 
exception.  During the initial lever press training, sessions ended after 30 min or 
following 40 trials (20 trials for each lever), whichever occurred first.  The 
magnitude discrimination and delay discounting sessions were conducted as 
described in Experiment 1.  
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Following 28 sessions of delay discounting, rats were killed, and brains 
were removed and flash-frozen in chromasolv (Sigma Aldrich; St. Louis, MO) on 
dry ice and stored at -80°C until sectioning was completed.  Coronal brain 
sections (16 µm) were taken and used for in vitro receptor autoradiography.  
For NMDA receptor autoradiography, sections were first preincubated for 
30 min at room temperature (RT) in buffer containing 5 mM Tris HCL and 2.5 mM 
CaCl2 (pH 7.4), then incubated for 90 min at room RT in fresh buffer containing 
10 nM [3H]MK-801, 5 µM glutamic acid, 100 µM glycine, and 5 µM spermidine.  
After incubation, slides were washed three times in ice cold 5 mM Tris-HCl buffer 
for 20 min, followed by one wash in 0.5 mM Tris-HCl buffer and one wash in 
double distilled water.  Slides were air dried and stored overnight before filming.  
Slides containing the brain sections were placed into a light-proof cassette and 
exposed to Kodak film.  Films were developed following 6 weeks of exposure.    
For DAT autoradiography, sections were preincubated for 15 min at RT in 
buffer containing 50 mM Tris-HCL, 120 mM NaCl, and 5 mM KCl (pH 7.4), then 
incubated for 120 min in fresh buffer containing 50 pM [125I]-RTI-121, 120 mM 
NaCl, 5 mM KCl, .001% ascorbic acid, .025% BSA, and 1 µM fluoxetine.  After 
incubation, slides were washed four times in ice cold 50 mM Tris-HCl buffer for 
30 min, followed by one wash in 5 mM Tris-HCl buffer and one wash in double 
distilled water.  Slides were air dried and stored overnight before filming.  Slides 
containing the brain sections were placed into a light-proof cassette and exposed 
to Kodak film. Films were developed following 3 days of exposure.   
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For NMDA receptor and DAT autoradiography, [3H]-MK-801 and [125I]-RTI-
121 binding data were analyzed with Image J (http://imagej.nih.gov/ij).  NAcc and 
NAcSh in each hemisphere were outlined manually, and mean binding density 
was calculated for each individual animal (4-6 coronal sections were analyzed for 
each animal). Binding densities in the left and right hemisphere were averaged to 
form one value for each animal.  
Statistical Analyses 
 For the autoradiography experiment, only the top third of impulsive rats 
(HiI; n =8) and bottom third of impulsive rats (LoI; n = 7; one brain for a LoI rat 
was destroyed during extraction) were used in data analysis.  To ensure that 
discounting in rats selected as HiI and LoI was different, parameter estimates k 
(log transformed; note: there were a couple of instances in which an animal 
chose the large magnitude reinforcer every single free-choice trial; therefore, 
their log-transformed k value had to be arbitrarily set at -5.0) and A were 
analyzed with a mixed-factor ANOVA, with session block (7 levels; 7 4-day 
blocks) as a within-subjects factor and impulsivity (HiI vs. LoI) as a between-
subjects factor (note: separate ANOVAs were conducted for k and A).  
For NMDA receptor and DAT binding, mean [3H]-MK-801 and [125I]-RTI-
121 binding densities in the NAcc and NAcSh were compared between HiI and 
LoI rats with independent-samples t tests.  Statistical significance was set at p < 
.05 in all cases.   
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Results 
 Figure 3.1 shows discounting performance in HiI and LoI rats at different 
time points during training.  During training, the proportion of choices for the 
large, delayed reinforcer decreased as a function of delay for both HiI and LoI 
rats, although HiI rats responded less for the large magnitude reinforcer relative 
to LoI rats as the delay to its delivery increased.  Figure 3.2 shows parameter 
estimates of k (log transformed) and A in HiI and LoI rats across 4-day blocks.  
For k (log transformed) parameter estimates, results from the mixed-factor 
ANOVA indicated main effects of session block (F(6, 84) = 6.96, p < .05, ηp2 = 
.33) and impulsivity (F(1, 14) = 12.79, p < .05, ηp2 = .48).  The session block × 
impulsivity interaction approached statistical significance (F(6, 84) = 2.17, p = 
.054, ηp2 = .13).  These results show that across training, both HiI and LoI rats 
became more sensitive to delay; however, HiI rats showed greater sensitivity to 
delay reinforcement relative to LoI across training (Figure 3.2A).  For A 
parameter estimates, results from the mixed-factor ANOVAs revealed a main 
effect of impulsivity (F(1, 14) = 4.80, p < .05, ηp2 = .26; Figure 3.2B).  Overall, HiI 
rats were less sensitive to reinforcer magnitude relative to LoI rats.  This 
difference was most pronounced during the first three session blocks.  A 
separate Mann-Whitney t test was conducted to compare A parameter estimates 
in HiI and LoI rats during the final block of sessions.  Results from the t test 
revealed no differences in sensitivity to reinforcer magnitude.     
  Figure 3.3 shows a schematic of the NAcc and NAcSh, and Figure 3.4 
shows representative autoradiograms for [3H]-MK-801 (Panel A) and [125I]-RTI-
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121 binding (Panel B).  For NMDA receptor binding (Figure 3.5A), there were no 
differences between HiI and LoI rats in NMDA receptor binding within NAcc or 
NAcSh.  
For DAT binding (Figure 3.5B), there were no differences between HiI and LoI 
rats in DAT binding within NAcc or NAcSh.  
Discussion 
 In the current experiment, there were no statistically significant differences 
in NMDA receptor or DAT expression in HiI and LoI rats.  Overall, these results 
suggest that differences in delay discounting do not result from baseline 
differences in NAc NMDA receptor or DAT expression.  
 There is a growing interest in the role of Glu, particularly the NMDA 
receptor, in impulse control disorders such as attention deficit hyperactivity 
disorder (ADHD; see Chang, Lane, & Tsai, in press for a recent review).  A 
recent pilot study showed that the noncompetitive NMDA receptor antagonist 
memantine is efficacious in reducing the inattentive and hyperactivity subtypes of 
ADHD (Surman et al., 2013).  Also, atomoxetine, a norepinephrine reuptake 
inhibitor, acts as an NMDA receptor antagonist at clinically relevant 
concentrations (Ludolph et al., 2010).  Recent evidence suggests that drugs 
currently used to treat ADHD decrease NMDA receptor expression (Udvardi et 
al., 2013; Urban, Li, & Gao, 2013).     
Given the growing interest in NMDA receptors in impulsivity, the current 
experiment sought to determine if NMDA receptor binding is altered in HiI and 
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LoI impulsive rats.  The results showed that NMDA receptor density within NAcc 
and NAcSh did not differ significantly in HiI and LoI rats.  Considering NMDA 
receptors are upregulated following MK-801 administation (McDonald, 
Silverstein, & Johnston, 1990), the hypothesis of the current experiment was that 
HiI rats would have decreased NMDA receptor expression in NAcc relative to LoI 
rats.  The current results suggest that differential sensitivity to delayed 
reinforcement does not result from baseline differences in NMDA receptor 
expression in NAc.   
Interpreting the current results is somewhat difficult for a couple of 
reasons.  First, NMDA receptors are composed of different subunits: NR1 and 
NR2 (A-D; see Ozawa et al., 1998).  Using the current protocol, [3H]MK-801 
binding does not show selectivity for NMDA receptor NR2 subunits.  Examining 
NMDA subunit expression (e.g., using [3H]ifenprodil to target NR2B containing 
receptors) in HiI and LoI rats may provide some insight for the individual 
differences observed in delay discounting performance.  Second, MK-801 blocks 
synaptic and extrasynaptic NMDA receptors (Xia, Chen, Zhang, & Lipton, 2010). 
Synaptic NMDA receptors are functional receptors that are activated by Glu 
released during low-frequency synaptic events, whereas extrasynaptic receptors 
are not activated during low-frequency synaptic events are found at various 
locations on a neuron (see Hardingham & Bading, 2010 for a review).  Future 
work will need to determine if HiI and LoI rats differ in the number of synaptic or 
extrasynaptic NMDA receptors.  
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Studying DAT binding in the NAc was of interest because DAT is believed 
to mediate impulsive behavior, as administration of DAT inhibitors are efficacious 
in treating impulse control disorders (see Biederman & Faraone, 2005) and 
decrease impulsive choice in humans (de Wit et al., 2002; Pietras, Cherek, Lane, 
Tcheremissine, & Steinberg, 2003; Shiels et al., 2009) and animals (Baarendse & 
Vanderschuren, 2012; Broos et al., 2012; Floresco et al., 2008; Pitts & McKinney, 
2005; van Gaalen et al., 2006).  Also, DAT binding is lower in individuals with 
ADHD (Krause, Dresel, Krause, Kung, & Tatsch, 2000).  In the current 
experiment, there were no differences in DAT density within NAcc and NAcSh 
between HiI and LoI rats.  These results were somewhat surprising because 
previous studies have shown that lentiviral-mediated overexpression of DAT in 
the NAcc increases impulsive choice (Adriani et al., 2009) and that LoI rats have 
greater electrically evoked DA release within NAcc and NAcSh (Diergaarde et al., 
2008).  Despite these discrepancies, the current findings are consistent with data 
showing no correlation between impulsive choice and DAT function (as assessed 
with kinetic analysis of [3H]DA uptake) within OFC or mPFC (Marusich, Darna, 
Charnigo, Dwoskin, & Bardo, 2011).  Directly comparing the current results with 
previous studies is difficult because the methodologies used to assess the 
relationship between DAT and impulsive decision differed across studies (e.g., in 
vitro receptor autoradiography vs. electrically evoked DA release).  
One major caveat of in vitro autoradiography needs to be discussed. 
Autoradiography provides a measure of the number of receptors/transporters in a 
brain region but does not identify functional differences.  Although the number of 
 
	  
	   55 
NMDA receptors or DATs did not differ in the NAcc between HiI and LoI rats, 
there is a possibility that functional differences exist.  For example, Diergaarde et 
al. (2008) found reduced DA release in mPFC and NAc of HiI rats relative to LoI 
rats.  Using alternative approaches that measure receptor/transporter function 
are needed to determine the precise phenotypic differences in HiI and LoI 
animals.  Despite this caveat, the current results show that differences in delay 
discounting are not necessarily the result of baseline differences in NAc NMDA 
receptor or DAT expression.    
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Figure 3.1. Delay discounting performance in HiI rats (Panel A) and LoI rats 
(Panel B) across session blocks (average of four sessions per block). 
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Figure 3.2. Mean (± SEM) k parameter estimates (log transformed; Panel A) and 
A parameter estimates (Panel B) in HiI rats and LoI rats across session blocks 
(average of four sessions per block). *p < .05, relative to LoI rats.  
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Figure 3.3. Schematic showing the location of NAcc (outlined in solid line) and 
NAcSh (outlined in dashed line).  
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Figure 3.4. Representative autoradiograms of [3H]-MK-801 radioligand NMDA 
receptor binding (Panel A) and [125I]-RTI-121 radioligand DAT binding (Panel B).   
A 
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Figure 3.5. Binding densities of [3H]-MK-801 to NMDA receptors (Panel A) and 
[125I]-RTI-121 to DAT (Panel B) in HiI and LoI rats.  
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Chapter 4: Experiment 3 
Introduction  
Although MK-801 decreased impulsive choice in Experiment 1, 
interpreting the results can be difficult considered MK-801 blocks nicotinic 
acetylcholine receptors (Amador & Dani, 1991; Briggs & McKenna, 1996) and 
increases DA levels within the prefrontal cortex (Tsukada et al., 2005).  To better 
evaluate the role of Glu NMDA receptors in impulsive decision making, a drug 
that shows higher selectivity for NMDA receptors can be administered.  One such 
drug is AP-5, which is competitive antagonist at NMDA receptors (Crunelli, 
Forda, & Kelly, 1983).  
Another issue is that using MK-801 as a pharmacotherapy for impulse 
control disorders is not ideal because MK-801 disrupts learning in animals 
(Harder, Aboobaker, Hodgetts, & Ridley, 1998; Li et al., 2011; Rapanelli, Frick, 
Bernardez-Vidal, & Zanutto, 2013; van der Staay, Rutten, Erb, & Blokland, 2011) 
and is often used to model symptoms of schizophrenia (see Lim, Taylor, & 
Malone, 2012 for a review).  One potential alternative approach is to use an 
antagonist that targets a specific splice variant of the NMDA receptor, as eight 
variants of the NR1 subunit (1a-4a; 1b-4b) and four variants of the NR2 subunit 
(A-D) have been identified (Hollmann et al., 1993; Monyer et al., 1992; see 
Ozawa et al., 1998 for a review).  One such drug is ifenprodil, which selectively 
antagonizes NR2B-containing NMDA receptors (Perin-Dureau, Rachline, Neyton, 
& Paoletti, 2002).  Ifenprodil is neuroprotective in in vivo models of ischemia 
(Gotti et al., 1988), but lacks the psychomimetic-like effects observed with NMDA 
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receptor antagonists like MK-801 (Narita, Aoki, & Suzuki, 2000).  Furthermore, 
ifenprodil attenuats the rewarding effects of opiates (Ma, Yu, Guo, & Cui, 2011; 
Ma et al., 2006; Suzuki, Kato, Tsuda, Suzuki, & Misawa, 1999), suggesting that 
NR2B subunits are important mediators of the drug addiction process.  
Thus, the primary goal of Experiment 3 was to determine the effects of 
intra-NAcc infusions of MK-801, AP-5, and ifenprodil on delay discounting 
performance.  Animals also received infusions of the AMPA receptor antagonist 
CNQX.  CNQX was included as a negative control, as the results from 
Experiment 1 showed that CNQX does not alter impulsive decision making.  The 
primary hypothesis of this study was that intra-NAcc infusions of NMDA receptor 
antagonists would decrease impulsive choice.  
A secondary goal was to examine the effects of intra-NAcc infusions of 
selective DA receptor ligands on impulsive choice.  Typically, increasing DA 
levels decreases impulsive choice (e.g., Broos et al., 2012a; Cardinal, Robbins, 
& Everitt, 2000; de Wit et al., 2002; Pitts & McKinney, 2005; van Gaalen, van 
Koten, Schoffelmeer, & Vanderschuren, 2006b; Winstanley et al., 2003).  Thus, 
the hypothesis was that stimulating D1-like receptors with SKF-38393 or blocking 
D2-like autoreceptors with eticlopride would decrease impulsive choice.  
Materials and Methods 
Animals 
 A total of 24 male, individually-housed Sprague Dawley rats (Harlan 
Industries; Indianapolis, IN) were used in the experiments.  Rats weighed 
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approximately 250-275 g upon arrival to the laboratory.  Rats were acclimated to 
a colony room held at a constant temperature and were handled for 5 days upon 
arrival.  Light and dark phases were on a 12:12 h cycle, and all experiments 
occurred during the light phase.  Rats were food restricted (approximately 80% of 
free feed body weight) 3 days before the beginning of behavioral training, and 
rats remained on food restriction during the remainder of the study, unless 
otherwise noted. 
Drugs 
(+)-MK-801 hydrogen maleate, D(-)-2-amino-5-phosphonopentanoic acid, 
6-cyano-7-nitroquinoxaline-2,3-dione disodium salt hydrate, (±)-SKF-38393 
hydrochloride, (±)-SCH-23390 hydrochloride, (-)-quinpirole hydrochloride, and S-
(-)-eticlopride hydrochloride were purchased from Sigma Aldrich (St. Louis, MO).  
Ifenprodil hemitartrate was purchased from Tocris Bioscience (Ellisville, MO).  
Each drug was prepared in sterile 0.9% NaCl (saline), and concentrations were 
calculated based on salt weight.    
Apparatus  
 The apparatus was identical to the one used in the Experiment 1.  
Procedure  
 The procedures were identical to those described in Experiment 2.  
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Surgery 
 After 32 sessions of delay discounting, rats were treated with the 
nonopioid analgesic carprofen one day prior to surgery.  Rats were anesthetized 
with a mixture of ketamine, xylazine, and acepromazine (75, 7.5, and 0.75 mg/kg, 
i.p., respectively) and were secured into a stereotaxic frame.  Cannulae were 
implanted bilaterally into NAcc (+1.6 AP, ± 1.5 ML, -5.5 DV) at the 10° angle off 
the midline; Paxinos & Watson, 1998).  Following surgery, rats were treated with 
carprofen for two days.  
Microinfusions 
Rats recovered for 3-5 days and were food restricted before receiving 12 
additional training sessions in the delay discounting task.  This additional training 
was important to ensure that surgery did not alter discounting behavior.  For 
intracranial infusions, rats were gently restrained by the experimenter, and a 
stainless-steel injection cannula (33 gauge; Small Parts, Inc, Miramar, FL) was 
inserted 2 mm below the tip of the guide cannulae.  The cannulae were 
connected to 10 µl syringes (Hamilton, Reno, NV) via PE10 tubing (Small Parts, 
Inc, Miramar, FL).  The Hamilton syringes were mounted on an infusion pump 
(KDS Scientific, Holliston, MA).  Half of the rats (n = 12) received direct infusions 
of ionotropic glutamate receptor ligands MK-801 (noncompetitive NMDA channel 
blocker; 0.0, 0.3, and 1.0 µg/0.5 µl; Bakshi & Geyer, 1998; Zhang, Bast, & 
Feldon, 2000), AP-5 (competitive NMDA antagonist; 0.0, 0.3, and 1.0 µg/0.5 µl; 
Baldwin, Holahan, Sadeghian, & Kelley, 2000; Dar, 2002; Sombers, Beyene, 
 
	  
	   65 
Carelli, & Wrightman, 2009), ifenprodil (NR2B subunit antagonist; 0.0, 0.3, and 
1.0 µg/0.5 µl; Parkes & Balleine, 2013; Laurent & Westbook, 2008), and CNQX 
(AMPA antagonist; 0.0, 0.2 and 0.5 µg/0.5 µl; Hitchcott & Phillips, 1997; 
Mesches, Bianchin, & McGaugh, 1996).  The other half of the rats (n = 12) 
received direct infusions of the dopamine receptor ligands SKF 38393 (D1-like 
agonist; 0.0, 0.03 and 0.1 µg/0.5 µl; Loos et al., 2010; Yates et al., under review), 
SCH 23390 (D1-like antagonist; 0.0, 0.3, and 1.0 µg/0.5 µl; Loos et al., 2010; 
Yates et al., under review; Zeeb et al., 2010), quinpirole (D2-like agonist; 0.0, 0.3, 
and 1.0 µg/0.5 µl; Yates et al., under review), eticlopride (D2-like antagonist; 0.0, 
0.3, and 1.0 µg/0.5 µl; Yates et al., under review; Zeeb et al., 2010).  Each drug 
was infused over 2 min at a rate of 0.25 µl/min.  Injectors were left in place for 1 
min following the infusion.  Rats were placed into the operant chamber 
immediately following the infusion.  Treatments were randomly administered, and 
rats were given 2 days of washout following each infusion; rats were tested in 
delay discounting during these washout days.   
Following the last day of infusions, rats were anesthetized with ketamine, 
and brains were removed and flash-frozen in chromasolv (Sigma) on dry ice and 
stored at -80°C until sectioning was completed.  Brain sections (40 µm) were 
sliced to determine the location of guide cannulae.  Probe placements were 
evaluated according to the atlas of Paxinos and Watson (1998).  Only data from 
rats with correct probe placements in NAcc were used in statistical analyses.  
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Statistical Analyses 
 To determine if implantation of guide cannulae into NAcc altered 
sensitivity to delayed reinforcement or sensitivity to reinforcer magnitude, 
discounting performance before surgery (average of final four sessions) was 
compared to discounting performance after surgery (average of final four 
sessions before first microinfusion).  Parameter estimates of k (log transformed) 
and A were analyzed with a mixed-factor ANOVA, with surgery (Pre vs. Post) as 
a within-subjects factor and experiment (Glu vs. DA) as a between-subjects 
factor.  For each individual experiment, omissions and parameter estimates from 
the hyperbolic discounting function were analyzed as described in Experiment 1. 
Results 
 Figure 4.1 shows the proportion of choices for the large, delayed 
reinforcer as a function of delay averaged across the final four sessions before 
surgery and averaged across the final four sessions after surgery, prior to the 
first microinfusion of either Glu-selective ligands or DA-selective ligands.  
Analysis of k and A parameter estimates revealed that surgery did not alter 
sensitivity to delayed reinforcement or sensitivity to reinforcer magnitude (Figure 
4.2).  Furthermore, baseline levels of discounting were similar for animals 
selected to subsequently receive Glu-selective ligands and DA-selective ligands 
(Figure 4.2).   
Figure 4.3 shows a representative image of bilateral guide cannulae 
implantation into NAcc.  Four rats in Experiment 1A (Figure 4.4) and six rats in 
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Experiment 1B (Figure 4.5) had probe placements outside of NAcc, and were 
thus excluded from further analyses  
Figures 4.6 and 4.7 show the proportion of choices for the delayed 
reinforcer following all concentrations of MK-801, AP-5, ifenprodil, and CNQX.  
The proportion of choices for the large delayed reinforcer decreased as function 
of the delay to receiving reinforcement. 
 Figures 4.8 and 4.9 show omissions following all concentrations of MK-
801, AP-5, ifenprodil, and CNQX.  AP-5 increased overall omissions (χ2(2) = 
8.00, p < .05), although Wilcoxon post hoc tests did not reveal significant 
differences between vehicle and either dose (each p > .025; Bonferroni 
correction; Figure 4.8B).  MK-801 (Figure 4.8A), ifenprodil (Figure 4.9A), and 
CNQX (Figure 4.9B) did not alter omissions.  
 Figures 4.10 and 4.11 show k parameter estimates following all 
concentrations of MK-801, AP-5, ifenprodil, and CNQX.  None of the Glu-
selective ligands produced a statistically significant change in k parameter 
estimates.   
 Figures 4.12 and 4.13 show A parameter estimates following all 
concentrations of MK-801, AP-5, ifenprodil, and CNQX.  None of the Glu-
selective ligands significantly altered sensitivity to reinforcer magnitude. 
 Figures 4.14 and 4.15 show the proportion of choices for the delayed 
reinforcer following all concentrations of SKF 38393, SCH 23390, quinpirole, and 
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eticlopride.  The proportion of choices for the large delayed reinforcer decreased 
as function of the delay to receiving reinforcement.  
Figures 4.16 and 4.17 show omissions following all concentrations of SKF 
38393, SCH 23390, quinpirole, and eticlopride.  Intra-NAcc infusions of DA-
selective ligands did not alter omissions. 
Figures 4.18 and 4.19 show k parameter estimates following all 
concentrations of SKF 38393, SCH 23390, quinpirole, and eticlopride.  None of 
the DA-selective ligands produced a statistically significant change in k 
parameter estimates.   
Figure 4.20 and 4.21 show A parameter estimates following all 
concentrations of SKF 38393, SCH 23390, quinpirole, and eticlopride.  None of 
the DA-selective ligands altered sensitivity to reinforcer magnitude.  
Discussion  
In the current experiment, intra-NAcc infusions of NMDA-selective ligands 
and DA-selective ligands did not significantly alter delay discounting.  Although 
none of the ligands infused into NAcc caused a statistically significant difference 
in the rate of discounting using traditional statistical methods, this does not mean 
that Glu and DA receptors within this region do not necessarily mediate impulsive 
choice.  Large effect sizes were reported for MK-801, ifenprodil, SKF 38393, and 
eticlopride (Cohen’s f’s > .60), indicating that these drugs decreased impulsive 
choice.  One potential reason a statistical difference was not detected for these 
drugs is the small sample sizes used in each experiment (Glu experiment: n = 8; 
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DA experiment: n = 6).  Similarly, baseline levels of impulsive choice may 
influence the effects of intra-NAcc infusions.  For example, administration of 
methylphenidate increases delay discounting in LoI rats, but decreases 
discounting in HiI rats (Perry, Stairs, & Bardo, 2008b).  Due to the relatively small 
sample sizes, examining the effects of Glu-selective and DA-selective drugs on 
discounting in HiI and LoI rats was not feasible.  
It has been argued that research needs to switch from null-hypothesis 
testing (i.e., reporting p values) to using effect sizes estimates (i.e., Cohen’s d, 
Cohen’s f, eta squared; Cumming, 2014; Kirk, 2003).  Other critics of null-
hypothesis testing argue that hypothesis testing impedes scientific progress 
(Kirk, 2003), and some have even suggested that some research findings are 
false because hypothesis testing creates bias in data interpretation (Ioannidis, 
2005).  Based on effect size estimates, the current data provide some evidence 
that blockade of NR2B containing NMDA receptors and DA receptors within 
NAcc mediate impulsive decision making.  
In Experiment 1, systemic administration of MK-801 significantly 
decreased impulsive choice.  However, intra-NAcc MK-801 infusions did not 
significantly decrease sensitivity to delayed reinforcement.  One possibility for 
this discrepancy is that direct infusion of MK-801 (1.0 µg) lesioned the NAcc (see 
Olney, Labruyere, & Price, 1989 for a discussion).  However, this interpretation 
does not seem likely, as lesions to NAcc increase impulsive choice (e.g., 
Cardinal et al., 2001).  Also, considering that the effect size estimates obtained 
for MK-801 in Experiment 1 (Cohen’s f = .67) and the current experiment 
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(Cohen’s f = .61), the current results provide some support that intra-NAcc 
infusions of MK-801 decrease impulsive choice.  
The current experiment provided some evidence that direct administration 
of ifenprodil decreased impulsive choice (Cohen’s f = .62).  Thus, the NR2B 
subunit may be an important mediator of impulsive decision making.  This 
interpretation is further supported by the finding that intercereboventricular and 
intra-NAcc administration of the competitive NMDA receptor antagonist AP-5 
does not affect delay discounting (Cottone et al., 2013; current experiment).  
Considering that selective blockade of NR2B subunits does not produce 
amnesiac or dissociative effects like noncompetitive channel blockers (e.g., MK-
801; Narita et al., 2000), ifenprodil may be a promising pharmacotherapy for 
treating impulse control disorders.  Furthermore, ifenprodil has been shown to be 
effective in attenuating the rewarding effects of opiates (Ma et al., 2011; Ma et 
al., 2006; Suzuki et al., 1999).  Future studies will need to test the efficacy of 
ifenprodil in reducing the reinforcing effects of psychostimulants, although one 
report showed that ifenprodil blocks the discriminative stimulus effects of cocaine 
in monkeys (Fujiwara et al., 2007). Furthermore, future work is needed to test the 
effectiveness of therapeutically relevant doses of ifenprodil in reducing 
impulsivity.    
DA systems are thought to play a critical role in impulsive choice, 
especially in delay discounting (see Winstanley, 2011 for a review).  Considering 
that medications used to treat impulse control disorders release DA levels (see 
Biederman & Faraone, 2005) and decrease impulsive decision making (Broos et 
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al., 2012a; Cardinal et al., 2000; de Wit et al., 2002; Pitts & McKinney, 2005; van 
Gaalen et al., 2006b; Winstanley et al., 2003), it was hypothesized that 
increasing SKF 38393 (D1-like agonist) and eticlopride (D2-like antagonist) 
would decrease impulsive choice.  Increasing DA levels by stimulating D1-like 
receptors and inhibiting D2-like autoreceptors did not significantly alter delay 
discounting.  Similar to the results with MK-801 and ifenprodil, the effect sizes 
reported for SKF 38393 (Cohen’s f = .64) and eticlopride (Cohen’s f = .61) were 
large, which provides some support for the hypotheses.  Regardless, these data 
do not corroborate previous research examining the role of DA receptor ligands 
in impulsive decision making.  A previous study found increased discounting 
following intra-mPFC infusions of SKF 38393 (Loos et al., 2010).  Loos et al. 
(2010) also observed increases in impulsive choice after blocking D1-like 
receptors with SCH 23390, an effect not observed in the current experiment.  
Given that the discounting procedure used by Loos et al. (2010) was similar to 
the current procedure, it is not entirely clear why discounting was differentially 
altered following SKF 38393 administration.  However, intra-mPFC administration 
appears to have produced a slight decrease in choice for the large magnitude 
reinforcer when its delivery was immediate (Loos et al., 2010), an effect observed 
following systemic administration (Koffarnus et al., 2011).  Thus, D1 receptors 
within mPFC and NAcc may differentially mediate sensitivity to reinforcer amount 
and delayed reinforcement.   
DA D2-like receptors are autoreceptors, which decrease DA synthesis and 
packaging (Onali, Oliansa, & Bunse, 1988; Pothos, Davila, & Sulzer, 1998).  
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Therefore, blocking these receptors should decrease the rate of discounting. 
However, previous studies have observed increases in impulsive choice following 
intra-mPFC or intra-OFC administration of the D2-like receptor antagonists 
raclopride and eticlopride (Pardey et al., 2013; Zeeb et al., 2010).  One 
discrepancy between the current experiment and previous studies is the use of a 
discriminative stimulus to signal the delay to delivery of the large magnitude 
reinforcer.  In the current experiment, no cue was used to signal the delay, 
whereas Pardey et al. (2013) and Zeeb et al. (2010) used a cue light.  Zeeb et al. 
(2010) found that eticlopride increased impulsive choice when a cue was used, 
whereas impulsive choice was unaltered if a cue was not used.  Thus, future 
studies are needed to understand how intra-NAcc administration of DA D2-like 
antagonists affect impulsive decision making when cues are used to signal the 
delay to reinforcement.   
One limitation to this study was the use of two concentrations for each 
drug tested.  The number of drug concentrations was limited because the 
number of microinfusions needs to be limited in order to minimize damage to the 
brain region.  Future work will be needed to assess a wider range of drug 
concentrations of NMDA and DA receptor ligands within NAcc and NAcSh to 
further elucidate the role of NAc Glu and DA systems in controlling impulsive 
choice.  Furthermore, examining the role of other neurotransmitter systems within 
NAc is merited.  For example, NAc contains 5-HT and GABA receptors (Biegon, 
Rainbow, & McEwen, 1982; Bowery, Hudson, & Price, 1987), and these 
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neurotransmitters influence impulsive decision making (Bizot et al., 1999; Liu et 
al., 2004; Zeeb et al., 2010).    
Another important consideration is that several brain regions have been 
implicated in impulsive decision making, such as OFC (Mobini et al., 2002; 
Winstanley et al., 2004b; but see Churchwell et al., 2009), mPFC (Churchwell et 
al., 2009; but see Cardinal et al., 2001), amygdala (Churchwell et al., 2009; 
Winstanley et al., 2004b), dorsal striatum (Dunnett et al., 2012), and 
hippocampus (Abela & Chudasama, 2013; Cheung & Cardinal, 2005; Mariano et 
al., 2009).  Also, DA receptors within OFC and mPFC are known to contribute to 
delay discounting performance (Loos et al., 2010; Yates et al., under review; 
Zeeb et al., 2010).  Future studies are needed to assess the role of NMDA 
receptors in other brain regions (e.g., frontal cortices and hippocampus) in 
mediating impulsive behavior.  
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Figure 4.1 Mean (± SEM) proportion of choices for the large magnitude 
reinforcer as a function of the delay to receiving reinforcement before and after 
surgery in rats subsequently given Glu-selective ligands and DA-selective 
ligands.  
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Figure 4.2 Mean (± SEM) k parameter estimates (log transformed; Panel A) and 
A parameter estimates (Panel B) before and after surgery in rats subsequently 
given Glu-selective ligands and DA-selective ligands.  
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Figure 4.3. Representative image of bilateral guide cannulae implantation into 
NAcc.  
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Figure 4.4. Schematic of coronal sections showing probe placements for rats 
infused with Glu-selective ligands. Black circles indicate probe placements within 
NAcc, whereas crosses indicate probe place placements outside of NAcc. Note 
that rats with probe placements outside of NAcc were excluded from data 
analysis. Numbers beside each plate correspond to mm anterior to bregma.  
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Figure 4.5. Schematic of coronal sections showing probe placements for rats 
infused with DA-selective ligands. Black circles indicate probe placements within 
NAcc, whereas crosses indicate probe place placements outside of NAcc. Note 
that rats with probe placements outside of NAcc were excluded from data 
analysis. Numbers beside each plate correspond to mm anterior to bregma.  
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Figure 4.6. Mean (± SEM) proportion of choices for the large magnitude 
reinforcer as a function of the delay to receiving reinforcement following intra-
NAcc infusions of MK-801 (Panel A) and AP-5 (Panel B).  
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Figure 4.7. Mean (± SEM) proportion of choices for the large magnitude 
reinforcer as a function of the delay to receiving reinforcement following intra-
NAcc infusions of ifenprodil (Panel A) and CNQX (Panel B).  
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Figure 4.8. Mean (± SEM) omissions during free-choice trials following intra-
NAcc infusions of MK-801 (Panel A) and AP-5 (Panel B). 
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Figure 4.9. Mean (± SEM) omissions during free-choice trials following intra-
NAcc infusions of ifenprodil (Panel A) and CNQX (Panel B).  
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Figure 4.10. Mean (± SEM) k parameter estimates (log transformed) following 
intra-NAcc infusions of MK-801 (Panel A) and AP-5 (Panel B).  
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Figure 4.11. Mean (± SEM) k parameter estimates (log transformed) following 
intra-NAcc infusions of ifenprodil (Panel A) and CNQX (Panel B). 
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Figure 4.12. Mean (± SEM) A parameter estimates following intra-NAcc infusions 
of MK-801 (Panel A) and AP-5 (Panel B).  
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Figure 4.13. Mean (± SEM) A parameter estimates following intra-NAcc infusions 
of ifenprodil (Panel A) and CNQX (Panel B). 
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Figure 4.14. Mean (± SEM) proportion of choices for the large magnitude 
reinforcer as a function of the delay to receiving reinforcement following intra-
NAcc infusions of SKF 38393 (Panel A) and SCH 23390 (Panel B). 
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Figure 4.15. Mean (± SEM) proportion of choices for the large magnitude 
reinforcer as a function of the delay to receiving reinforcement following intra-
NAcc infusions of quinpirole (Panel A) and eticlopride (Panel B).  
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Figure 4.16. Mean (± SEM) omissions during free-choice trials following intra-
NAcc infusions of SKF 38393 (Panel A) and SCH 23390 (Panel B). 
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Figure 4.17. Mean (± SEM) omissions during free-choice trials following intra-
NAcc infusions of quinpirole (Panel A) and eticlopride (Panel B).  
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Figure 4.18. Mean (± SEM) k parameter estimates (log transformed) following 
intra-NAcc infusions of SKF 38393 (Panel A) and SCH 23390 (Panel B). 
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Figure 4.19. Mean (± SEM) k parameter estimates (log transformed) following 
intra-NAcc infusions of quinpirole (Panel A), and eticlopride (Panel B).  
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Figure 4.20. Mean (± SEM) A parameter estimates following intra-NAcc infusions 
of SKF 38393 (Panel A) and SCH 23390 (Panel B). 
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Figure 4.21. Mean (± SEM) A parameter estimates following intra-NAcc infusions 
of quinpirole (Panel A) and eticlopride (Panel B).  
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Chapter 5: General Discussion 
 The primary goal of the current set of experiments was to elucidate the 
role of the glutamatergic and dopaminergic systems in impulsive choice.  The 
NAcc has been consistently linked to impulsive decision making (Bezzina et al., 
2007; Cardinal et al., 2001; da Costa Araújo et al., 2009; Pothuzien et al., 2005; 
Valencia-Torres et al., 2012); however, studies examining the role of NAcc in 
impulsive choice have relied on excitotoxic lesions.  Lesion studies do not 
indicate which specific neurotransmitter systems mediate this behavior.  
Therefore, the current experiments sought to determine if NAcc Glu and DA 
systems are a) altered in HiI and LoI animals, and b) to determine if NAcc Glu 
and DA receptors differentially alter impulsive choice.  The results from these 
studies demonstrated that: 1) systemic administration of MK-801, but not CNQX, 
decreases impulsive choice (Experiment 1); 2) differences in discounting do not 
result from baseline differences in NAc NMDA receptor or DAT expression 
(Experiment 2); and 3) intra-NAcc infusions of Glu-selective and DA-selective 
ligands do not significantly alter impulsive choice (Experiment 3).   
 In the current experiments, the term “impulsive choice” has been used to 
describe performance in delay discounting.  Although delay discounting is often 
described as a measure of impulsive choice (e.g., Ainslie, 1975; see Winstanley 
et al., 2010 for a review), some argue against this assertion.  For example, 
Blanchard, Pearson, and Hayden (2013) show that monkeys often fail to 
associate postreward delays with their choices and systematically underestimate 
the delay to reinforcement.  Blanchard et al. (2013) propose that discounting 
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does not necessarily reflect impulsivity, but may reflect other unrelated mental 
processes.  Furthermore, Killeen (2011) postulates that animals do not discount 
future rewards; instead, the data observed in discounting experiments merely 
reflects decay in memory traces.   
Despite these criticisms, studying delay discounting is important because 
performance in this task is often linked to maladaptive behaviors, such as 
pathological gambling (Petry, 2001b) and substance use disorders (Bickel et al., 
1999; Coffey et al., 2003; Madden et al., 1997; Mitchell, 1999; Vuchinich & 
Simpson, 1998).  As discussed in Chapter 1, animals showing increased 
sensitivity to delayed reinforcement are more likely to acquire psychostimulant 
self-administration at a faster rate (Perry et al., 2005, 2008a), to respond more 
for drug reinforcers (Diergaarde et al., 2008; Marusich & Bardo, 2009), and to be 
more susceptible to relapse-like behaviors (Diergaarde et al., 2008).   
It should be noted that delay discounting is not the only measure of 
impulsivity that is linked to drug abuse.  As with impulsive choice, the construct of 
impulsive action (i.e., behavioral disinhibition or motor impulsivity) has received 
considerable attention in the drug abuse field.  Cocaine (Fillmore & Rush, 2002; 
Li, Milivojevic, Kemp, Hong, & Sinha, 2006) and methamphetamine (Monterosso, 
Aron, Cordova, Xu, & London, 2005) users display inhibitory deficits in a SSRT 
task relative to nonusers. Furthermore, cocaine users (Hester & Garavan, 2004; 
Kaufman, Ross, Stein, & Garavan, 2003; Verdejo-Garcia, Perales, & Perez-
Garcia, 2007) and alcoholics (Noel et al., 2007) show increased inhibitory deficits 
on a go/no-go task compared to controls.  Impulsive action is predictive of drug 
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abuse vulnerability, as rats that exhibit increased impulsivity in the 5CSRT task 
show escalation of cocaine self-administration (Dalley et al., 2007), compulsive 
cocaine self-administration (Belin, Mar, Dalley, Robbins, & Everitt, 2008), and 
reinstatement of cocaine self-administration (Economidou, Pelloux, Robbins, 
Dalley, & Everitt, 2009).  
Like impulsive choice, motor impulsivity is altered by various drugs, and 
this effect is observed in humans and animals. Alcohol generally impairs 
inhibitory control in humans (de Wit, Crean, & Richards, 2000; Easdon, Izenberg, 
Armilo, Yu, & Alain, 2005; Fillmore & Vogel-Spott, 1999; Marczinski, Abroms, 
Van Selst, & Fillmore, 2005; Marczinski & Fillmore, 2003, 2005a, b; Mulvihill, 
Skilling, & Vogel-Sprott, 1997; but see Ortner, MacDonald, & Olmstead, 2003) 
and animals (Feola et al., 2000).  Also, cocaine administration increases 
impulsive action in humans (Fillmore, Rush, & Hays, 2002) and animals (Paine & 
Olmstead, 2004; van Gaalen, Brueggeman, Bronius, Schoffelmeer, & 
Vanderschuren, 2006a; Winstanley et al., 2009).    
Although impulsive choice and impulsive action are both linked to 
substance abuse, it should be emphasized that there is evidence that these 
facets of impulsivity are dissociable.  In humans and animals, impulsive choice 
and impulsive action are not correlated (Broos et al., 2012; Marusich et al., 
2011).  Also, lesions to the subthalamic nucleus decreases impulsive choice 
(Winstanley, Baunez, Theobald, & Robbins, 2005) but increase impulsivity as 
assessed in the 5CSRT task (Baunez et al., 2001) and impair prepotent 
response inhibition (Weiner, Magaro, & Matell, 2008).  Also, damage to OFC 
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alters delay discounting performance, albeit discrepancies have been reported in 
the literature (Mar et al., 2011; Mobini et al., 2002; Kheramin et al., 2002, 2004; 
Rudebeck et al., 2006; Winstanley et al., 2004b), whereas damage to OFC does 
not affect performance in the 5CSRT task (Chudasama et al., 2003).  
Furthermore, Experiment 2 showed that HiI and LoI rats had similar DAT densitiy 
within NAc, whereas a recent study found differential NAcSh DAT density in LoI 
rats relative to HiI rats performing a 5CSRT task (Jupp et al., 2013).  
Understanding the precise underlying neuromechanisms involved in distinct 
facets of impulsivity is important for providing effective pharmacotherapies for 
those who display different types of impulsive behavior.  Results from Experiment 
3 suggest that ifenprodil may be an effective treatment for reducing impulsive 
decision making.  It is unknown if ifenprodil will reduce motor impulsivity, 
although there is evidence that blockade of NR2B subunit with Ro 63-1908 
increases impulsive action (Burton & Fletcher, 2012; Higgims, Ballard, Huwyler, 
Kemp, & Gill, 2003).  Thus, targeting NR2B subunits may not be an effective 
treatment for those who display increased motor impulsivity.  
Although the current experiments focused on delay discounting, it is worth 
mentioning that other discounting procedures exist.  Specifically, the probability 
discounting procedure has received some attention.  This procedure is similar to 
delay discounting, but the odds against obtaining the large magnitude reinforcer 
increase (i.e., the probability of obtaining the reinforcer decreases).  There is 
some dispute as to whether delay and probability discounting measure similar 
constructs of impulsivity.  It has been proposed that delay and probability 
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discounting reflect a similar underlying process (Myerson & Green, 1995; Rachlin 
et al., 1991).  In support of this proposal, the same mathematical functions (e.g., 
hyperbolic) can be used to model delay and probability discounting (Rachlin et 
al., 1991).  Also, administration of amphetamine produces similar shifts in delay 
(van Gaalen et al., 2006b; Winstanley et al., 2003) and probability discounting 
(Floresco & Whelan, 2009; St Onge & Floresco, 2009).  Furthermore, lesions to 
NAc increase the rate of discounting for delayed (Cardinal et al., 2001) and 
probabilistic reinforcement (Cardinal & Howes, 2005).   
An important consideration is that similar shifts in delay and probability 
discounting following pharmacological manipulations does not necessarily mean 
that these tasks reflect the same process.  Evidence suggests that delay and 
probability discounting involve distinct processes, with delay and probability 
discounting reflecting impulsive choice and risky decision making, respectively 
(Ainslie, 1975; Kahneman & Tversky, 1979).  Although increased delay 
discounting is postulated to reflect impulsive choice (Ainslie, 1975), decreased 
probability discounting is proposed to reflect risky decision making (Kahneman & 
Tversky, 1979).  Thus, drugs that decrease the rate of discounting of delayed 
and probabilistic reinforcement differentially alter impulsive behavior, with 
decreased delay discounting reflecting higher self control and decreased 
probability discounting reflecting increased risky decision making.  
In line with this hypothesis, there is some support that delay and 
probability discounting are dissociable, as manipulating reinforcer magnitude 
differentially alters discounting of delayed and uncertain reinforcement (Green, 
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Myerson, & Ostaszewski, 1999), and forebrain depletion of 5-HT increases 
sensitivity to delayed reinforcement without altering sensitivity to probabilistic 
reinforcement (Mobini et al., 2000).  In addition to the data collected in 
Experiment 1, a separate group of rats were administered MK-801 and CNQX 
before performing a probability discounting task.  As in delay discounting, MK-
801 (0.03 mg/kg) increased responding for the large, uncertain reinforcer, 
whereas CNQX (5.6 mg/kg) decreased responding.  Overall, these results 
suggest that iGluRs differentially mediate impulsivity, with MK-801 decreasing 
impulsive choice but increasing risky decision making and CNQX increasing 
probability discounting without altering delay discounting.  Future work will need 
to assess the effects of ifenprodil on risky decision making to determine if 
selective NR2B antagonists attenuate risky decision making. Moreover, perhaps 
probability discounting would be an alternative approach for examining the 
specific role of DA and Glu systems in impulsive decision making using the 
current autoradiographic and microinjection techniques.   
One caveat to the current studies is that the delay to the large magnitude 
reinforcer increased across each block of trials.  The rate of discounting can be 
influenced by the order in which delays/odds against are presented (e.g, 
ascending, descending, or mixed order; Fox et al., 2008; Robles and Vargas 
2007, 2008; but see Slezak and Anderson 2009).  Furthermore, drug effects can 
be dependent on the order in which delays are presented (Tanno, Maguire, 
Henson, & France, 2014).  Specifically, Tanno et al. (2014) show that 
amphetamine and methylphenidate increase choice for the large, delayed 
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reinforcer when delays are presented in an ascending order, whereas a decrease 
in choice for the large reinforcer is observed when delays are presented in a 
descending order.  One could argue that the increase in responding for the large 
magnitude reinforcer observed in Experiments 1 and 3 following NMDA and DA 
D2-like receptor blockade or DA D1-like receptor activation could reflect an 
increase in the persistence of choice behavior rather than a change in sensitivity 
to delay.  Future work will need to randomize the order in which delays are 
presented in order to avoid this potential confound.   
 Another caveat to the current study relates to the upward shift in the 
discounting function following MK-801, ifenprodil, SKF 38393, and eticlopride 
administration.  Interpretation of these findings is difficult because we cannot rule 
out the possibility that the upward shift in discounting was attributed to increased 
sensitivity to reinforcer magnitude.  Indeed, a change in the A parameter 
(sensitivity to reinforcer magnitude) was observed following MK-801 
administration in the delay discounting task in Experiment 1. Because the 
proportion of choices for the large magnitude reinforcer is close to a ceiling (near 
1.0) when the delay to its delivery is set at 0 sec, an increase in responding for 
that reinforcer is difficult to observe following pharmacological manipulations.  
For example, certain drugs decrease responding for a large, delayed/uncertain 
reinforcer, even when the delay to its delivery is set at 0 sec (Cardinal et al., 
2000; Koffarnus et al., 2011; Mendez et al., 2012; van Gaalen et al., 2006b; 
Winstanley et al., 2005).  
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 Although promising, results from the current experiments are not fully 
conclusive about the specific role DA and Glu in NAcc, if any, in delay 
discounting and follow-up experiments are needed.  Considering the complex 
interactions between Glu and monoamine neurotransmitters (DA and 5-HT) 
within the mesocorticolimbic pathway (see Tzschentke, 2001 for a review), future 
studies should examine how these interactions control impulsive choice.  For 
example, there is evidence for DA:5-HT interactions to  mediate impulsive 
choice, as DA depletions within NAc block impulsivity induced by a 5-HT1A 
receptor agonist (Winstanley et al., 2005).  Also, there is some evidence for 
Glu:5-HT interactions, as administration of a mGluR2/3 receptor agonist 
attenuates 5-HT2A-induced impulsive choice (Wischof et al., 2011).  These 
studies can help further our understanding of the role of the glutamatergic system 
in impulsive choice.   
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